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1 INTRODUCTION 
The development of nano-sized drug carriers in pharmaceutical products has led to 
enormous improvements in therapeutical outcomes, especially in cancer treatment 
(Blanco 2009). Patients may benefit from nanotechnology by more efficient and accu-
rate drug delivery. The association of drug molecules with a nanocarrier can protect the 
drug from chemical and biological degradation and enable better control of drug release 
(Couvreur 2013). In addition, engineering with various targeting moieties can increase 
the specificity of drug delivery (Torchilin 2007). Although the delivery properties of 
nanocarriers are in general superior to conventionally formulated drug products, there 
are still many problems to be faced. The stability of the drug carrier, as well as the 
drug/drug carrier complex, has to be optimized for physiological conditions. Moreover, 
specific targeting and controlled drug release need to be assured. Drug loading and de-
livery properties are highly influenced by the chemical nature of the nanoparticulate 
carrier, as well as its size, shape and other physicochemical characteristics (Yoo et al. 
2011). However, the final performance of a drug carrier in a biological system seems to 
be difficult to predict (Siegwart et al. 2011). A combinatorial approach to test the drug 
delivery properties of a large number of different nanocarriers might be feasible. Auto-
mated synthesis and analysis of a nanoparticulate library in a high throughput manner 
could represent a fast way to optimize features of a nanocarrier for its intended target 
(Thomas et al. 2007).  
HCS is an expensive, but powerful analytical tool, which allows simultaneous analysis 
of multiple functional and structural parameters within one screen in a high throughput 
(HT) manner (Bickle 2010). Usually, the effect of a drug molecule on cell cultures or 
tissue sections is assessed. Analysis parameters might include receptor targeting, intra-
cellular localization, biochemical pathways and functional differences in subpopulations 
of cells. During the last few years, HCS has gained popularity in the pharmaceutical 
industry, speeding up the drug development process. HCS is usually applied for screen-
ing of potential drug molecules. However, HCS could represent an interesting option in 
the optimization of nanoparticulate carriers for a special target system.  
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The aim of this project was to test the applicability of HCS methodology in screening of 
a combinatorial library of nanocarriers in terms of cellular  drug delivery. For this pur-
pose, a small library of supramolecular structures, varying in size and shape with differ-
ent targeting moieties, should be synthetized. Physicochemical characterization and 
cytotoxicity testing was to be performed with suitable methodologies.  As a next step, 
the micellar library should be subjected to HCS, whereas suitable experimental and ana-
lytical parameters were to be elaborated. Finally, the results should give hints and reveal 
problematic issues for testing larger and more complex combinatorial nanoparticulate 
libraries by HCS. 
 
 
2 LITERATURE REVIEW 
2.1 Nanoparticles as drug carriers 
Nanocarriers can be described as ultradispersed solid supramolecular structures with a 
size as small as 1 to 1000 nm (Couvreur 2013). Most commonly nanocarriers consist of 
polymers, but other material, such as gold, carbon or silica are being investigated as 
well. A nanocarrier bears clear advantages compared to traditional formulations. The 
solubility of a hardly soluble drug and its plasma half-life time can be increased (Petros 
and DeSimone 2010). Furthermore, immunogenicity and toxicity of drugs may be 
reduced and usually more effective targeting is achieved. 
The first therapeutic application of a nanoscale drug carrier, a drug polymer conjugate, 
was reported in the 1950s. Polyvinylpyrollidone (PVP) was conjugated to mescaline, 
separated by a small peptide spacer (Petros and DeSimone 2010). This formulation 
prolonged the drug release from 20 h to 17 days. Later, in the 1960s the first liposomes 
were prepared. Up to date drug-polymer conjugates and liposomes are still the most 
investigated and developed nanocarriers. The first liposome based drug product (Doxil) 
was approved by the US Food and Drug Administration (FDA) in 1995 for the 
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treatment of Kaposi’s sarcoma (Petros and DeSimone 2010). On the other hand, 
polymer-drug conjugates are often based on polyethyleneglycol (PEG) as polymeric 
unit, which reduces immunogenicity and increases stability of peptides and proteins. 
PEG-l-asparaginase (Oncospar; Enzon) was approved by the FDA in 1994 for the 
treatment of acute lymphocytic leukemia (Duncan 2006).  
Especially in cancer research, polymer based nanocarriers have become popular (Blanco 
et al. 2009). Nowadays, several formulations based on liposomes and drug-polymer 
conjugates are successfully applied in clinical practice. However, other nanoparticulate 
structures, such as dendrimers and polumeric micelles are already investigated, some 
even in clinical trials. Each nanocarrier bears its own biological advantages and 
disadvantages. Particularly, polymeric micelles have nowadays gained much attention 
due to superior delivery properties of poorly soluble, hydrophobic drugs as compared to 
liposomes or dendrimers (Torchilin 2007). 
 
2.2 Polymeric micelles 
Polymeric micelles are colloidal dispersion of supramolecular structures, which consist 
of amphiphilic polymer units (Torchilin 2007). Amphiphilicity is a feature of molecules, 
which bear hydrophilic and hydrophobic moieties at different positions. Amphiphilic 
polymers are thus capable of interacting with polar and non-polar environments. In an 
aqueous environment and above a certain concentration the amphiphilic unimers self-
assemble spontaneously to form stable, mostly spherical structures with a lipophilic 
core and a hydrophilic shell (Figure 1 A). Depending on the chemical nature of the 
polymer units used, the micelles can be biodegradable or non-biodegradable. Often, an 
additional hydrophilic moiety, such as PEG, for the improvement of drug delivery 
properties, is attached to the shell. This outer layer is termed corona. Micelle size varies 
from usually 5 to 100 nm, whereas the final size can be controlled by the composition 
and nature of the polymer units, as well as the ionic strength of the dispersion (Vukovic 
et al. 2011). 
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Figure 1. A: Structure of a PEGylated, amphiphilic polymer unit and its corresponding 
micelle B: Schematic overview over self-assembly of polymeric micelles, mentioning 
the main influencing factors of the process. Micelles, as dynamic structures, are capable 
of exchanging single polymer units with free monomers from the environment or from 
other micelles. 
The micelle forming polymer used in this project was the amphiphilic polymer 
distearoylphosphatidylethanolamine - poly(ethylene glycol)2000 (DSPE-PEG2000) 
(Appendix, Figure 1 A). DSPE is a synthetic phospholipid, which has been approved by 
the FDA for medical applications (Wang et al. 2012). DSPE in its PEGylated form has 
been used widely in the preparation of different kinds of nanocarriers, such as 
PEGylated liposomes, polymeric micelles, micro emulsions, lipid polymer hybrid nano-
particles amongst others. The cancer drug product Doxil contains DSPE-PEG2000 as 
component of its liposomal structure (Vukovic et al. 2011).  
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2.2.1 Self-assembly  
In the self-assembly process, amphiphilic polymer units spontaneously form nano-scale 
supramolecular structures in an aqueous environment (Owen et al. 2012). Self-assembly 
is a thermodynamic process and its potential depends on mass and composition of the 
polymer, as well as polymer concentration. The driving force for self-assembly is a re-
duction of interfacial free energy within the system. The hydrophobic chains in aqueous 
solutions tend to aggregate and form the hydrophobic core of the micelles (Figure 1 A). 
The hydrophilic chains of the shell or corona are orientated towards the aqueous envi-
ronment. The hydrophobic chains are shielded from interaction with water. Thereby, the 
interfacial free energy of the system is minimized. Size and shape of the resulting mi-
celles can be controlled by properties of the amphiphilic polymer. The ratio between 
hydrophilic and hydrophobic segments, as well as their structure and geometry are im-
portant determinants for final micelle properties. Generally, when the hydrophilic seg-
ment is longer than the hydrophobic part, spherical micelles are favored. 
The packing parameter P gives an estimate for the shape of the resulting supramolecular 
structure and is valid for amphiphiles with their hydrophobic parts in liquid state 
(Shimizu et al. 2005). P is described by the following equation: 
   
 
    
 
V represents the volume of the hydrophobic chain, a0 is the surface area of the polar 
head at the critical micelle concentration (CMC), described in chapter 2.2.2, and lc the 
length of hydrophobic chain. In dependence on the value of P assemble into different 
shaped structures: P < ⅓: spherical micelles; ⅓ < P < ½: cylindrical micelles;  ½ < P < 
1: bilayers with curvature (vesicles,liposomes), P = 1: planar bilayers and P > 1: re-
versed micelles (Figure 2). Finally, environmental conditions during self-assembly, 
such as ionic strength of the solvent, pH, temperature and polymer concentrations, have 
an important impact on structure and geometry of the polymer chains and thus influence 
size and shape of micelles.  
 
(1) 
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One possibility for the estimation of micelle size is the aggregation number (Nag), which 
is the number of polymer units forming one micelle. Nag usually varies from tens to 
hundreds of monomers per micelle. There are different equations for the calculation of 
Nag (Owen et al. 2012). The most simple equation involves the molecular weight of the 
micelle M and the polymer backbone M0:  
     
 
  
 
Another equation for the measurement of Nag uses the hydrodynamic radius R of the 
micelle and intrinsic viscosity η:  
    
      
 
      
 
The molecular weight M of a micelle can be estimated by the following equation: 
 
    
     
 
   
 
NA is Avogadro’s number and ν
2
 is the partial specific volume of the polymer. 
However, polymeric micelles are not solid structures. The self-assembly of polymer 
chains is a physical process. Interactions between polymer chains are based on van der 
Waals and hydrogen bond interactions, rather than covalent bonding. In dependence of 
the polymer concentration, micelles exist next to free polymer chains in solution, form-
ing a dynamic equilibrium state (Figure 1 B). At this equilibrium state, an exchange of 
polymer chains from micelles with free polymer chains has been observed (Owen et al. 
2012).    
 
(2) 
(3) 
(4) 
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Figure 2. The packing parameter p influences the shape of nanostructures built from 
amphiphilic polymer units. 
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2.2.2 Critical micelle concentration (CMC) 
The CMC is an essential value, reflecting the thermodynamic stability of polymeric 
micelles (Owen et al. 2012). The CMC is defined as the concentration of polymer, at 
which micelles start to self-assemble. At concentrations below the CMC, monomers are 
energetically more favorable. Thus, the CMC is an indicator of micelle stability upon 
dilution. Lower CMC values indicate higher physical stability. Usually, the CMC of 
polymeric micelles lies in the range of 10
-5
 to 10
-7
 M, which indicates high physical 
stability and is significantly lower than for surfactant micelles (CMC ~10
-3
 to 10
-4
 M). 
For clinical application the CMC is extremely important, since it is predictive of micelle 
integrity upon injection into the circulatory system, where it is diluted manifold. 
The CMC can be determined with methods measuring changes in physical characteris-
tics occurring at the CMC, such as micelle size, change in optical characteristics or vis-
cosity of the suspension and surface tension measurements. Dynamic light scattering 
(DLS) is an example of an analytical technique, which enables determination of CMC, 
micelle size and polydispersity. However, fluorescence techniques for the determination 
of CMC offer higher sensitivity. Fluorescence based CMC measurements are based on a 
hydrophobic fluorophore, which partitions into the micelle core during self-assembly. 
The analysis is based on changes in the fluorophores spectroscopic properties, when 
translocated from an aqueous into a hydrophobic environment. Pyrene is a commonly 
used fluorophore in CMC measurement, which shows two characteristic emission bands 
at λ = 373 nm (I1) and λ = 383 nm (I3) (Figure 3). Upon pyrene association into the hy-
drophobic micelle core, the intensity of peak I3 increases in relation to I1. Thus, the in-
tensity ratio I1/I3 decreases. The CMC can be determined by plotting the I1/I3 ratio 
against the log of the polymer concentration, which is described in more detail in chap-
ter 3.3.5.  
 
9 
 
 
Figure 3. Changes in emission spectrum of pyrene upon inclusion into micelles. In a 
hydrophilic environment the peaks I1 and I3 show almost identical intensities. Upon 
self-assembly at the CMC, the entrapment of pyrene into the hydrophobic core of mi-
celles leads to an increase in peak I3 in relation to I1 (Wei et al. 2005). 
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2.2.3 Polymeric micelles in drug delivery 
Polymeric micelles bear clear advantages compared to other nanoparticulate drug carrier 
systems. Especially very hydrophobic drugs, such as most cancer drugs, display poor 
absorption and low bioavailability upon oral uptake (Torchilin 2007). Furthermore, 
aggregation after i.v. administration is possible. This can lead to serious side effects, 
such as embolism, local toxicity or non-effective therapeutic outcomes. In drug 
discovery, about half of potentially effective drug candidates are highly hydrophobic. 
Thus, their development is discontinued already in early stages, irrespective of their 
effectiveness on the target. Polymeric micelles are capable of dissolving larger amounts 
of hydrophobic drugs in their core than are liposomes (Petros and DeSimone 2010). 
Moreover, the dissolution process of drugs into micelles is simple. During self-assembly 
the hydrophobic drug is encapsulated into the core of the micelle, erasing the need for 
conjugation or other chemical modifications. In addition, hydrophilic drugs can be 
adsorbed or chemically linked to the shell or corona of the micelles. The drug is 
protected from chemical and biological degradation as long as the micelles stay intact 
under physiological conditions. However, polymeric micelles have to face certain 
challenges, such as loading efficiency, translocation over cell membranes and blood 
stability after injection (Kim et al. 2010). In addition, cytotoxicity has to be tested in 
vitro in a suitable cell culture system or by in vivo animal studies. 
 
2.2.4 Stability in biological systems 
As described before, polymeric micelles are thermodynamically very stable structures, 
indicated by their low CMC. High stability leads to longer circulation times in vivo and 
thus can increases plasma half-life of the encapsulated drug. Binding to plasma proteins 
or other blood constituents can influence in vivo performance of polymeric micelles 
(Kim et al. 2010). Plasma binding is highly dependent on the chemical nature of the 
polymer. Another factor leading to increased circulation time is the masking of micelles 
to prevent recognition and degradation by the immune system (Blanco 2009). To date 
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the only way to prevent immunogenicity of micelles is reduction of surface charge or 
introduction of hydrophilic groups onto the surface (Petros and DeSimone 2010). 
However, the ratio of hydrophilic to hydrophobic groups for optimal cell uptake varies 
among cell lines (Zhang et al. 2013). Most commonly, hydrophilic corona-forming 
polymers are used, which by their brush-like structure act as steric protection from 
phagocytic degradation, by inhibiting particle recognition. The most popular corona-
forming polymer nowadays is polyethyleneglycol (PEG) in a size range from 2 to 15 
kDa (Torchilin 2007). Moreover, PEG increases solubility and stability of nanocarriers 
in plasma and is FDA approved for clinical applications.  
 
2.2.5 Cellular uptake and trafficking  
Given the polymeric micelle has reached its target cell via the systemic circulation 
without degradation, cellular uptake is a major barrier to successful drug delivery. The 
cell membrane blocks passive diffusion of particles larger than 1 kDa into the cell 
(Petros and DeSimone 2010). Micellar uptake usually occurs by an endocytotic path-
way. The exact mode of cell entry is important, since it determines the further traffick-
ing of the micelle through or into subcellular compartments. Endocytotic pathways 
comprise phagocytosis, clathrin-mediated endocytosis (CME), calveolae-mediated en-
docytosis (CvME), macropinocytosis and other distinct endocytotic pathways, which 
are independent of clathrin and calveolae (Hillaireau and Couvreur 2009). All 
endocytotic pathways involve vesicle formation. However, only phagocytosis and CME 
involve entrapment in acidified and enzyme containing lysosomal compartments. Thus, 
taken up by these routes, the micelles need to endure an acidic environment and have to 
be capable to escape endosomes in order to deliver the drug to any intracellular target. 
Possible mechanism for lysosomal escape of nanocarriers are described further in chap-
ter 2.3. Consequently, a nanocarrier encounters different conditions, depending on its 
pathway of internalization. Internalization pathways for the same nanoparticle can differ 
between cell types and there might be more than one mechanism involved in uptake into 
the same cell (Zhang et al. 2013; Hillaireau and Couvreur 2009). Phagocytosis is pre-
ferred in mononuclear cells of the reticuloendothelial system (RES), whereas CME is a 
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major way of uptake for nutrients in almost all mammalian cells. Though, it has been 
shown that identical monomethoxy poly(ethylene glycol)-block-poly(ε-caprolactone) 
fluorescein isothiocyanate (mPEG-PCL-FITC) micelles were preferentially internalized 
via macropinocytosis, CvME and macropinocytosis into the HUVEC cell line, whereas 
the main uptake mechanism into HepG2 cells was CME (Zhang et al. 2013). Moreover, 
most of the endocytotic pathways rely on specific receptor- ligand interactions or other 
specific interactions with surface proteins of the cell membrane. It is known that lig-
ands, such as folate, cholesterol or albumin are internalized by CvME, whereas transfer-
rin and epidermal growth factor (EGF) use mainly CME for cell entry (Hillaireau and 
Couvreur 2009).  
Other properties, which affect cell uptake comprise surface charge, hydrophilicity, size 
and shape of nanocarriers. Due to the generally negative charge of the cell surface, posi-
tively charged particles interact more easily and are thus more likely to be taken up by 
the cell. Also hydrophilicity has recently gained more attention in cell internalization. 
Zhang et al. found a pattern in cell uptake of mPEG-PCL-FITC micelles in different cell 
lines, which showed a clear correlation to the ratio of hydrophilic:hydrophobic surface 
moieties (Zhang et al. 2013). Moreover, the hydrophilic corona forming polymer PEG 
in PEG-poly-hexadecylcyanoacrylate (PHDCA) nanospheres was shown to increase 
affinity to endothelial cells of the blood brain barrier (BBB) (Brigger et al. 2002).  
The impact of particle size and shape on single cell internalization has long been 
underestimated. Endocytic pathways imply vesicles bearing certain size limits, such as 
100 nm for CME and 50 to 80 nm for CvME (Hillaireau and Couvreur 2009). Many 
studies have shown a size preference in the uptake of nanoparticles into cell lines. Only 
recently, shape effects for cell internalization have been observed as well. Although, to 
date no consistent shape tendency for enhanced cell internalization could be found. 
Some studies have shown a faster rate of endocytosis for spherical particles, whereas 
other studies found preferential uptake of rod-shaped or cylindrical particles (Gratton et 
al. 2008, Muro et al. 2008). Finally, in vivo performance is influenced by cellular uptake 
mechanisms and their influencing factors, such as surface charge, hydrophilicity, size, 
shape of a nanoparticle and targeting. Thus, these factors have to be considered 
carefully in the design of a nanocarrier.  
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2.2.6 Targeting of polymeric micelles 
Targeting of polymeric micelles can be divided into active or passive strategies (Petros 
and DeSimone 2010). The passive targeting relies on the Enhanced Permeability and 
Retention Effect (EPR), which is relevant mainly in oncological applications and 
inflammatory conditions. The effect is based on the fact, that vasculature is more leaky 
in tumor tissues and areas of inflammation than in healthy tissues. This allows 
macromolecules of 10 to 100 nm, which is within the size window of polymeric 
micelles, to pass into the tissue. Moreover, the particles mostly remain at the site of 
infiltration, due to inefficient drainage. In general particles < 10 nm are cleared by the 
kidneys and particles in a size range from 100 to 200 nm are cleared by phagocytes of 
the reticuloendothelial system (Petros and DeSimone 2010; Ilium et al. 1982). Thus, 
polymeric micelles exhibit a favorable size distribution for escape from fast clearance. 
Active targeting strategies are based on attachment of targeting molecules to the corona 
of the micelles (Torchilin 2007). The targeting is based on the specific interaction of the 
attached ligand with an overexpressed receptor in cancer tissue. Such ligand-receptor 
pairs comprise transferrin/transferrin-receptor and folate/folate-receptor. Though, the 
specificity of the targeting is not very high, since these receptors are expressed to some 
extent in non-pathological tissues as well. A more specific approach is achieved by 
targeting receptors or other unique surface molecules, which are exclusively expressed 
in the pathological tissue. Such approaches include specific antibodies, aptamers, 
peptides and oligonucleotides. Especially various peptide sequences, acting as signaling 
or triggers for specific cell uptake have become very popular for active targeting 
approaches. 
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2.3 Cell penetrating peptides (CPPs) 
CPPs are a diverse class of peptides, varying from 5 to 40 amino acids, which are 
capable of internalization into mammalian, plant and bacterial cells (Koren and 
Torchilin 2012). CPPs have been isolated from different classes of functional proteins 
and peptides: RNA/DNA-binding proteins, signaling peptides, antimicrobial peptides, 
viral proteins, other natural proteins and peptide libraries. Depending on their origin, 
CPPs have the ability not only to penetrate cells, but also to reach specific intracellular 
targets, which makes them a valuable tool for targeted drug delivery.  Since 2001, the 
FDA has approved ten CPP based drugs for clinical applications (Miletti 2012).  
In terms of amino acid sequence, CPPs vary greatly. Though, it is possible to identify 
three major chemical classes: cationic, amphiphatic and hydrophobic, whereas 82 % of 
all CPPs carry a net positive charge. Mechanisms of cell entry can be various and the 
origin of a CPP can already give hints for a special pathway. All kinds of endocytosis 
and direct translocation through the membrane have been observed. Though, the exact 
mechanism of cell entry depends on factors, such as properties of CPPs and attached 
cargo, concentrations and target cell type (Jones and Sayer 2012). Moreover, 
experimental conditions, such as fixation of cells, has been shown to alter intracellular 
localization of certain CPPs (Richard et al. 2012). Varying mechanisms of cell entry 
have been observed for the same CPP at different concentrations. Direct translocation 
seems to be favored at higher CPP concentrations and smaller CPP or cargo molecules. 
Though, a net positive charge or a hydrophobic domaine within the peptide seems to be 
involved in most internalization mechanisms (Koren and Torchilin 2012). It has been 
shown that at least eight positive charges are necessary for efficient uptake of many 
cationic CPPs. Positively charged poly-arginine motifs mediate efficient cell 
penetration. The guanidine head group of the arginine interacts through hydrogen 
bonding with the negatively charged phosphates and sulfates on the cell membrane, 
which promotes cell internalization (Koren and Torchilin 2012). Guanidine has been 
also shown to interact with and bind cell surface glycosaminoglycans (GAGs) before 
internalization. Positive charges can furthermore be introduced by lysine and proline 
rich motifs, though they are less efficient for intracellular delivery than guanidines. 
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Nuclear localization sequences (NLS) are usually rich in lysine. Thus, lysine containing 
CPPs are a suitable vector for nuclear delivery, when combined with a more efficient 
cell penetrating sequence. 
Endosomal/lysosomal escape represents another challenge for intracellular delivery. 
Depending on the mechanism of cell entry, CPPs might get trapped in the acidic 
environment of endosomes, and later lysosomes, where they are exposed to chemical 
and enzymatic degradation. Though, peptides or their conjugated nanovectors can be 
modified to endure or escape endosomal compartments.  Endosomal escape can be 
realized by utilizing the proton sponge effect (Martin and Rice 2008). The use of 
polymers or amino acids, which are easily protonated in an acidic environment, leads to 
swelling and disruption of the endosomal vesicles. The polymer polyethylenimine 
(PEI), bearing easily protonatable amine groups, and the amino acid histidine, are 
commonly used examples for the design of vehicles for endosomal escape. A second 
strategy involves fusogenic peptides. These peptides contain a high content of basic 
residues. In the more acidic environment of the endosome, the peptide changes its 
conformation to form an -helix with separate hydrophilic and hydrophobic interfaces. 
Those structures interact with the endosomal membrane in a way, which leads to 
disruption of the membrane or at least pore formation. 
Finally, there are also drawbacks of CPPs as targeting moieties for drug delivery. In 
analogy to peptide drugs, CPPs are sensitive to biological degradation in vivo. 
Furthermore, CPPs do usually not show tissue or cell specificity. Thus, CPPs potentially 
penetrate all cells they reach, which can lead to increased toxicity of the delivered drug 
(Koren and Torchilin 2012). 
In this project two different CPPs were used: transactivator of transcription (TAT) and 
RGD peptide. 
 
16 
 
2.3.1 Transactivator of transcription (TAT) 
The TAT peptide was the first CPP discovered (Miletti 2012).  TAT has been isolated 
from the HIV-1 protein of the human immunodeficiency virus (HIV) type 1. As a nu-
clear peptide, TAT was expected to successfully deliver drugs into the nucleus. Thus, 
the arginine-rich, cationic peptide has been successfully used as carrier and targeting 
moiety for many different drugs, proteins or nanocarriers. TAT labeled micelles, loaded 
with paclitaxel, have shown higher cytotoxicity towards cancer cells in vitro and in vivo 
(Savant and Torchilin 2009). Though, the mechanism of cell entry, as well as the ability 
of the TAT peptide for intranuclear delivery are still controversial. In accordance to 
other CPPs the delivery properties of TAT seem to depend on the nature of cargo, con-
centrations and experimental conditions (Koren and Torchilin 2012; Subrizi et al. 2012; 
Richard et al. 2003). Moreover, different fragments of the TAT peptide have been stud-
ied, whereas a sequence of at least nine amino acids (RKKRRQRRR) has been found to 
be crucial for cell uptake. The TAT(48-60) peptide is illustrated in the APPENDIX . 
 
2.3.2 RGD-peptides 
RGD peptides are a distinct class of CPPs. The arginine-glycine-aspartic acid (RGD) 
motif binds specifically to integrin receptors (Chen and Chen 2011). Integrins represent 
one class of cell adhesion molecules (CAMs), which are involved in distinct intercellu-
lar and cell-extracellular matrix (ECM) interactions. Moreover, integrins are 
endocytosed as well as exocytosed during cell locomotion and migration. The integrin 
family consists of over 20 members of heterodimeric transmembrane glycoproteins 
(with an  and  subunit). However, the RGD motif is recognized by over half of the 
integrin receptors. Integrins shows a tissue specific expression. While overexpressed in 
angiogenetic endothelial cells, no integrin receptors are found on pre-existing 
endolthelium. Tissue specific expression of receptors and receptor mediated cell inter-
nalization make integrin ligands a suitable carrier for targeted drug delivery into leuko-
cytes and neoblastic cells for cancer treatment or other inflammatory diseases. Thus, 
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RGD peptides as drug carriers and targeting moieties have gained popularity. Linear, as 
well as cyclic RGD peptide derivates have been conjugated to peptide drugs and 
nanocarriers. Though, cyclic RGD peptides seem to be even more efficient in targeted 
drug delivery. The RGD peptide used in this project is described and illustrated in the 
Appendix.  
 
2.4 Click chemistry and thiol–click reaction 
The term ‘click chemistry’ was first introduced by prof. Barry Sharps group in 1999 at 
the 217
th
 Chemical Society annual meeting (Hein et al. 2008). The main idea was to find 
molecules, which are ‘easy to synthesize’. Click chemistry comprises various chemical 
reactions, which are highly specific, simple to perform and robust with high yields. The 
reactions can be performed in water or low concentrated buffers. Usually there is no 
need for protective agents and the purification process of the product is simple. Click 
chemistry bonding is covalent and in most cases insensitive to cleavage under physio-
logical conditions. 
Click chemistry has nowadays simplified the synthesis and modification of polymeric 
drug delivery systems, leading to increased stability of the drug carrier.  
Click chemistry reaction can chemically be divided into four major groups: 
 
1. Cycloadditions: Usually 1,3-dipolar cyclo additions and hetero Diels-Alder 
cyclo additions. 
2. Nucleophilic ring openings: Opening of strained cyclic heterophiles, such as 
epoxides, cyclic sulfates or aziridines. 
3. Carbonyl chemistry of non-aldol type: formation of ureas, hydrazones or 
oximes. 
4. Additions to carbon multiple bonds: nitrosyl halide additions, epoxidations and 
some Michael additions. 
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The thiol-Michael addition, also called thiol-click reaction, used in this project belongs 
to the forth group of click chemistry reactions.  It is widely used in polymer conjuga-
tions, surface modifications of various nanocarriers and formation of hydrogels (Hoyle 
et al. 2010). The Michael addition itself can be described as a special kind of 1,4-
addition (Nair et al. 2013). A strong nucleophile attacks the -carbon of an -
unsaturated carbonyl, resulting in a stable adduct, bearing a new C-C, C-S or other C-X 
bond. The thiol-click reaction is one special kind of Michael addition. The nucleophilic 
attack on the carbonyl is performed by a thiolate anion, which has been generated by the 
catalysis of a base (Figure 4A). The resulting intermediate enolate anion is unstable and 
thus readily deprotonates to result in a stable (Figure 4 B and C). At the same time the 
base catalyst is recovered. However, the efficiency and sensitivity of the thiol-click re-
action depends on the nature of the reactants and solvents. A crucial step is the for-
mation of the thiolate anion, which can act as the nucleophile. Depending on the solvent 
and chemical context of the molecule, thiol groups exhibit quite variable pKa values. 
Thus, the efficiency of different thiols to deprotonate and act as nucleophiles can vary 
significantly. The same applies for the electron deficient carbonyl. Depending on the 
chemical surrounding, the unsaturated carbonyl is more or less reactive. In this project, 
the maleimide group was used as the unsaturated carbonyl reactant (Figure 5). It is one 
of the most reactive compounds in the context of thiol click reactions due to its high 
bond angle distortion and thus ring strain. Moreover, the carbonyl groups are in cis-
confirmation in highly polar solvents, which further increases its reactivity and can even 
erase the need for base catalysis. Moreover, the maleimide reaction with thiols is highly 
selective for thiols. Thus, formation of non-wanted side products is minimized. 
 
2.5 Analytical technologies for micelle characterization 
2.5.1 Matrix assisted laser desorption ionization – time of flight (MALDI-TOF) 
MALDI-TOF is mass spectrometric method, which generates data about structure and 
mass of molecules. Since MALDI-TOF uses a soft ionization technique compared to  
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Figure 4. The base catalyzed Thiol-Click reaction: A: base (B) catalyzed formation of 
the thiolate nucleophile (RS
-
). B: nucleophile attack of the thiolate to an activated car-
bon double bond. The activation occurs by an electron withdrawing group (EWR). An 
unstable enolate is the product of this reaction C: the enolate deprotonates the base and 
thus results in a stable conjugate (Hoyle et al. 2010).  
 
Figure 5. Schematic overview over the Maleimide-Thiol conjugation, which was car-
ried out in this project. 
 
other mass spectrometric methods, even large molecules and molecular mixtures can be 
desorbed and ionized (Montaudo 1995). Moreover, the degree of damage to the mole-
cule and the ionized fragments is quite low, which enables reliable analysis of whole 
polymers, oligomers and functional groups. Thus, MALDI-TOF has become a popular 
analysis method in polymer chemistry for the identification of molecular weight or 
weight distribution of the polymer, its functional groups as well as structural infor-
mation (Krüger 2006). 
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As shown in Figure 6, the MALDI-TOF measurement is based on the ionization of the 
sample, which has been mixed on a grid with an excess of matrix (Shimadzu 2013). The 
matrix is a chemical, which readily absorbs ultra violet (UV) light from a nitrogen laser 
(λ = 337 nm) and converts the absorbed energy into heat. This transfer of heat energy is 
a rapid process and leads to vaporization and ionization of the sample, together with a 
small amount of matrix. The ionized fragments are accelerated according to their size 
and charge and fly readily out of the source, where they have been ionized. The ionic 
fragments fly through a drift tube into the TOF-tube. At the end of the TOF-tube the 
total flight time of the distinct fragments is recorded. The velocity of the fragments de-
pends on the ratio of their size and charge (m/z).  In general, larger fragments fly more 
slowly and arrive later at the detector than small fragments. Thus, by detecting the time 
of flight, the size of a fragment can be recalculated via the m/z ratio. 
 
Figure 6. Schematic function of a MALDI-TOF mass spectrometer (MPI for Plant 
Breeding Research 2013). A laser transfers energy to the specimen, where the probe and 
matrix are mixed. The matrix absorbes and transferes the energy into heat. Probe and 
matrix molecules are rapidly evaporized and ionized into fragments of different charge 
and size. The fragments (red dashed line) fly through a drift tube into the TOF-tube, 
where they are finally detected at different times. The velocity of the fragments is ruled 
by their ratio of mass to charge (m/z), whereas high ratio-fragments (bigger) fly slower 
and are detected later than smaller ones (red dots).  
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2.5.2 Dynamic Light Scattering (DLS)  
DLS is an optical method, which allows measurement of particle size in the submicron 
range (Malvern 2013). Moreover, DLS has been used to determine CMC values. The 
size measurement is based on the Brownian motion of particles in dispersion. Brownian 
motion is described by the movement of particles due to collisions with other particles 
or solvent molecules. Small particles move faster than bigger ones. The size of the par-
ticles is expressed as hydrodynamic diameter d(H), which is the diameter of a sphere, 
that exhibit the same translational diffusion coefficient as the particle. d(H) can be cal-
culated by the Stokes-Einstein equation: 
   
      
  
    
 
 
 
D is the translational diffusion coefficient, k the Boltzmann’s constant, T the absolute 
temperature and η the viscosity of the solution.  
However, the hydrodynamic diameter is influenced by several factors. The ionic 
strength of the dispersion medium influences the thickness of the electric double layer, 
which surrounds particles in dispersion. The lower the ionic strength of the medium, the 
more extended the ionic double layer. Thus, a low conductivity medium will result in a 
larger, apparent hydrodynamic diameter compared to a high conductivity medium. 
Moreover, the shape of a particle can influence the diffusion speed in the medium de-
pending on the particles orientation.  
The actual DLS measurement is performed in a small sample cell or micro titer plate. A 
laser illuminates the sample, whereas a small portion of light is scattered by the particles 
(Figure 7). For optimal detection, the intensity of scattered light has to be in a defined 
range. An attenuator regulates the light exposure on the sample. The scattered light is 
recorded on a detector screen, that is positioned at an angle of 90 
0
 or 173 
0
, depending 
on the measurement device. The output on the screen is pattern of dark and light spots, 
called speckle pattern, which represent the particles at a respective time point. The size 
information can be derived with different algorithms. Output parameters include mean 
(5) 
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size (z-average diameter) and polydispersity index, which is an indicator for the width 
of the size distribution. Moreover, the size distribution can be illustrated as a function of 
scattered light intensity, particle volume or particle number. The difference of these 
three methods, when plotted as a function of relative % in class, is illustrated in Figure 
8. Equimolar amounts of 5 nm and 50 nm particles are measured. The number distribu-
tion results in two identical peaks, since equal amounts of both particles are present. 
Though, the volume of an identical amount of 5 nm particles is 1000 x smaller, than the 
volume of the 50 nm particles. This is due to the fact, that the volume increases with the 
third potency (volume of a sphere = 4/3π(d/2)3). Similarly, the intensity of the scattered 
light of the 5 nm particles is much smaller than for the 50 nm particles. Thus, the per-
centage of light intensity from the 50 nm particles is much higher, although the same 
amount of 5 nm particles is present. The peak for the smaller particles is here even 1 
000 000 x smaller, since the intensity of scattered light is proportional to d
6
. 
 
Figure 7. Schematic representation of a DLS measurement according to the Malvern 
Zetasizer instruments. A sample of dispersed particles is illuminated by a laser beam. 
The intensity of the laser is regulated by an attenuator. The scattered light of the parti-
cles is detected either at 90
0
 or 173
0
, according to the measurement device. The result-
ing picture has the form of a speckle pattern, consisting of dark and light spots, which 
represent single particles at a certain time point. Finally, the data are processed by a 
correlator and transferred into size data (Malvern 2013). 
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Figure 8. Different possibilities of visualizing particle size distributions of equimolar 
amounts of 5 nm and 50 nm particles. A: Analysis by number reveals peaks of same 
size for both populations. B: In anlaysis by volume the bigger particles exhibit a 1000 x 
higher percentage of total volume. C: In size distribution by intensity the larger particles 
shows an even 1 000 000 x higher percentage. 
 
2.5.3 Transmission Electron Microscopy (TEM) 
Electron microscopy in biomedical research has two main application fields. First, the 
confirmation of data, derived by other biochemical methods. Second, structural analysis 
of probes, which cannot be analyzed by other methods (Harris 2000). During the last 
years, TEM analysis has become an important method for the analysis of morphology 
and composition of nanoscaled samples in pharmaceutical research. The basic setup of a 
TEM microscope is analogical to an optical microscope (Figure 9). Though, in TEM an 
electron beam passes through a set of electromagnetic lenses instead of optical ones, 
which requires high vacuum conditions. The wavelength of an electron beam is about 
100000 x smaller than in a beam of optical light (Erni et al. 2009). Since smaller wave-
lengths lead to higher resolution, nanoscaled structures can be visualized with TEM. 
The resolution of a TEM microscope can be as high as 0.2 nm and particles down to 2 
nm in size can reliably visualized (Klang et al. 2013). Generally, the thickness of the 
specimen must not exceed a few hundred nanometers for electrons to pass through the 
probe (Koning and Koster 2009). Though, the specimen is visualized and contrast is 
given by elastic scattering of electrons hitting probe molecules. Inelastic scattering, as it  
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Figure 9. Basic functional components of a transmission electronmicroscope in com-
parison to a light microscope (University of Iowa 2013). 
 
occurs with increasing thickness of the specimen, leads to more background noise in the 
final image. Image contrast in TEM can also be achieved by phase or amplitude con-
trast, which can be regulated by the technical setup. Moreover, for lipid samples, nega-
tive staining can be applied for increasing the contrast. In general, TEM analysis is only 
feasible for dry samples. Though, it is possible to analyze particles in suspensions by 
cryo- or freezing methods (Klang et al. 2013).  
 
 
2.5.4 Confocal laser scanning microscopy (CLSM) 
CLSM is one out of several fluorescence based microscopic techniques, which is widely 
used in the analysis of biological samples. Fluorescence labeling of target molecules 
and cellular structures enables investigations on cellular trafficking and other biological 
pathways. Thus, CLSM is an important tool for the determination of drug delivery 
properties in pharmaceutical research (Pygall et al. 2007). But also physical characteri-
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zation of various pharmaceutical systems, such as colloids or pellets, as well as surface 
roughness of tablets, has become very popular.  
The confocal microscope was first introduced in 1955 by Minsky (Minsky 1988). Ac-
cording to Minsky, the advantages of confocal microscopy, compared to conventional 
microscopy were reduced blurring due to light scattering, increased resolution, im-
proved signal to noise ratio and unusually clear observation of thick and light scattering 
objects. These advantages make confocal microscopy particularly valuable for fluores-
cence based image analysis. Another advantage of nowadays CLSM technology is the 
possibility of imaging not only in xy-, but also xz- and yz- plane of a specimen. 
As shown in Figure 10, confocal microscopy, in contrast to wide field microscopy, fo-
cuses on a thin section of the sample, which can be as thin as 0.5 µm (University of Zü-
rich 2013). This is achieved by a pinhole in front of an objective and condensing lens to 
exclude out-of-focus light (Watson et al. 2005) (Figure 11). Moreover, the pinhole di-
ameter determines the thickness of the image section and is optimized for each objective 
(Leica 2013a). The low illumination intensity through the pinhole has been increased by 
the use of laser light as source of illumination (Pygall et al. 2007). For fluorescence ap-
plications, the wavelength of the laser is chosen according to the excitation spectrum of 
the fluorophore in use. The corresponding excitation spectra are usually recorded using 
filters for the respective emitted wavelengths. Though, the company Leica uses a spec-
trophotometer detection system (SP), which erases the need for filters (Leica 2013b). As 
illustrated in Figure 12, the emitted light from the focal plane is passed through a prism, 
whereas separation into bands of different wavelength occurs. Thus, the whole spectrum 
of emitted light can be recorded and analyzed. This system is applied in the Leica TCS 
SP5 confocal microscope, which was used in this project.  
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Figure 10. Differences in confocal and wide filed imaging. A: In confocal microscopy 
only a very thin layer is imaged, which allows the detection of targets in different 
depths of the sample. B: The optical section in wide field microscopy is quite big and 
superimposed targets cannot be visualized separately (University of Zurich 2013). 
 
 
 
 
 
Figure 11. In confocal microscopy a pinhole exludes laserlight which focal point is be-
low or above the intended focal plane (A and B). C: Only light, which focuses at the 
intended section is passed through (University of Zürich 2013).  
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Figure 12. The Leica spectrophotometer detection system. The emitted light from the 
specimen is split into discrete bands by a prism. Movable mirror sliders can be used to 
redirect the intended bands to the respective detectors (Leica 2013b). 
 
2.5.5 Image cytometry 
Image cytometry is a tool to derive quantitative data from cells or tissues by either ste-
reological (e.g. areas, volumes, lengths) or photometric (e.g. fluorescence, absorbance) 
measurements (Cieco et al. 2013). A combination of microscopy and digital imaging 
offers a wide range of analytical possibilities for basic research, as well as drug devel-
opment applications.  
Usually, an image cytometer is equipped with up to four lasers of different wavelength 
as source of light and for excitation of fluorescence dyes. The beams of the laser are 
combined into a common coincident path. As shown in Figure 13 A, the laser light is 
guided through an objective before illuminating the sample. Emitted fluorescence is 
directed back through the objective towards four photomultiplier tubes (PMT). Each 
PMT detects laser light of a certain wavelength range and the fluorescence information 
is computationally recalculated via pixel information into a high resolution image. In 
addition, the morphology of a cell is imaged by the scattering of the laser light from the 
sample (Figure 13 B). Solid state sensors (SSS) collect the photons and transforms them  
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Figure 13. Schematic functional units of an image cytometer. A: Fluorescence meas-
urement optical path. B: Overview over the scatter/absorbance and fluorescence optical 
path and example pictures including their combined image (Henriksen 2010). 
 
into electrons and pixel information. The final picture is again recalculated computa-
tionally. Thus, the sample can be simultaneously analyzed for fluorescence and struc-
ture. The microscopic image based on light scattering and the fluorescence image can 
be superimposed to acquaint the maximum amount of information (Figure 13 B). All 
image cytometers require powerful software. Object parameters (e.g. shape, size, fluo-
rescence intensity, etc.) have to be set for the analysis software to recognize subcellular 
structures or other targets. In order to get reliable results, careful validation of acquisi-
tion and analysis parameters are of great importance. Due to the manifold analysis op-
tions, image cytometry represents an ideal platform for HCS screening, as it was used in 
this project as well. 
 
2.5.6 High Content Screening (HCS) 
HCS was developed in the late the 1990s to address the demand of analyzing huge 
amounts of individual cells on a subcellular level (Guiliano et al. 1997). The aim was to 
get as much functional information as possible on single cells or special subpopulations 
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out of one screen in a high throughput manner. Most interesting aspect for many 
biological processes is simultaneous information about multiple parameters in the cell 
populations. In contrast, high throughput screening (HTS) is focused on the detection of 
one single target only.   
The HCS technology is based on automated light microscopic imaging, either wide field 
or confocal, as well as automated image cytometry (Bickle 2010). The HCS 
microscopic platforms used in this project are described in chapter 3.4. In most cases 
fluorescence based tags are used to identify subcellular targets or other molecules of 
interest. Given the microscope is equipped with a thermostated chamber that enables 
gas exchange, even life cell imaging is possible. In an industrial environment HCS 
microscopes are equipped with a robot that can handle microtiter plates up to 1539 
wells (Taylor 2010). However, the main advantage of HCS devices is the powerful 
software that is capable of performing multi-parametric analysis yielding statistically 
robust and quantitative data (Bickle 2010). Thus, relations between the various image 
readouts and cell populations can be established. The main difference between HCS 
devices of distinct providers does not lie in the imaging technology, but in the software 
and its functionality. In general HCS statistical software can be divided into supervised 
(human input needed), and unsupervised (fully automated).  
HCS is nowadays applied in all stages of drug discovery, although its use as a tool for 
primary screens evolved just recently (Bickle 2010). The rate of false positives could be 
lowered, since phenotypes are characterized by several parameters. Moreover, the 
assessment of the direct biological outcome leads to more hits and erases the need for 
target validation. In general, HCS analysis and turned out to be more predictive than a 
combination of conventional biochemical assays. Finally, all hits from a successful HCS 
assay fulfill the minimum requirements for ADME, since they penetrate into cells.  In 
lead optimization HCS derived data provide mechanistic understanding of the affected 
biological pathways. Of special benefit in this stage is the direct multi-parametric 
analysis and clustering of data. For toxicological testing animal experiments could be 
reduced due to HCS assays performed in tissue sections. Though, the requirements for 
toxicology tests on tissue sections are very strict and have to be optimized to resemble 
the real physiological conditions. Genetic variations can be considered much easier by 
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in situ HCS toxicology screens compared to animal experiments. Altogether, the 
attrition rate in clinical trials could be reduced by application of HCS technologies in 
earlier developmental stages and thus avoid unnecessary expenses in a large scale.  
 
 
3 MATERIALS AND METHODS 
3.1 Polymeric micelles 
3.1.1 Polymeric backbone: DSPE-PEG2000 
All micelles were composed of the synthetic amphiphilic phospholipid 1,2-distearoyl-
sn-glycero-3-phosphoethanolamine, which was PEGylated with PEG2000 (DSPE-
PEG2000) (Avantilipids). The hydrophilic part of the polymer consists of the 
phosphatidylethanolamine head group and the PEG corona. For labeling with CPPs and 
AlexaFluorFluor568 (Lifetechnologies) the maleimide (MAL) functionalized derivate 
DSPE-PEG2000-MAL was used. The chemical structure of the polymers are presented 
in the Appendix. 
 
3.1.2 Labels: peptides and fluorescent dye 
Two different cysteine-functionalized peptides (synthetized by Dr. Maxim Antopolsky, 
CDR), RGD and TAT(48-60) (further referred to as TAT only), were conjugated to 
DSPE-PEG2000-MAL. The cysteine residues were separated from the peptides by an 
aminohexanoic acid linker. Moreover, the hydrophilic maleimide-functionalized fluo-
rescence dye AlexaFluor568-MAL (Life Technologies) was attached as a tag to the la-
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beled micelles of the combinatorial library. The chemical structure of the labels is illus-
trated in the Appendix. 
 
3.1.3 Self-assembly of non-labeled micelles 
Solutions of either 1 mg/ml (356 µM), 10 mg/ml (3560 µM) or 100 mg/ml (35600 µM) 
of DSPE-PEG2000 were prepared in either 1 M, 100 mM, 10 mM or 1 mM HEPES (4-
(2-hydroxyethyl)-1-piperazine ethanesulfonic acid) buffer at pH 7.2 respectively. For 
self-assembly, the polymer powder was dissolved in the respective buffer by vortexing 
for 5 to 10 s. Micellar solutions were stored at RT protected from light. 
 
3.1.4 Self-assembly of labeled micelles and the combinatorial library 
Labeled micelles were assembled as described for non-labeled micelles. Though, la-
beled micelles were only assembled in 10 mM and 1 mM HEPES. Moreover, varying 
molar percentages (further referred to only as %) of labeled polymers, such as DSPE-
PEG2000-MAL-TAT, DSPE-PEG2000-MAL-RGD and DSPE-PEG2000-MAL-dithiol-
MAL-AlexaFluor568, were included into the micelle mix. Figure 14 illustrates the exact 
composition of labeled micelles of the combinatorial library, including controls. 
 
3.2 Conjugations 
The conjugation of the cysteine functionalized peptides RGD and TAT to DSPE-
PEG2000-MAL was mediated via a click chemistry reactions as described in chapter 
2.4. For direct conjugation of AlexaFluor568 to DSPE-PEG2000-MAL, no thiol-
functionalized commercial derivate was available. Thus, firstly a dithiol linker (1,3-
propanedithiol) was conjugated to DSPE-PEG2000-MAL. In a second step, the free 
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thiol group of the dithiol was combined with a maleimide functionalized Alexa568 
derivate as illustrated in more detail in Figure 15. All conjugates were stored at 4 
0
C. 
 
Figure 14. Final composition of the micellar library. The conjugates of DSPE-
PEG2000-MAL are indicated only with the name of their labels, which are Alexa568, 
TAT and RGD. All percentages indicate molar percentages. 
 
 
Figure 15. The conjugation of DSPE-PEG2000-MAL to MAL-Alexa568 was per-
formed in two steps. First a linker, 1,3-propanedithiol, was conjugated to the maleimide 
group of the polymer. In the second step, the maleimide functionalized Alexa568 was 
conjugated to the thiol group of the linker. 
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3.2.1 1,3-propanedithiol  
All steps including 1,3-propanedithiol (Sigma-Aldrich) were carried out under the hood 
due to its toxic fume. First, 2 µmol of the polymer DSPE-PEG2000-MAL were 
dissolved in 6 ml of 1 mM HEPES. The equimolar amount of 1,3-propanedithiol was 
dissolved in 1 ml buffer and transferred into a brown glass bottle. Then, 1 ml polymer 
solution was combined with the dithiol solution and stirred at 4 
0
C for 30 min. The rest 
of the polymer solution was added in aliquots of 1 ml every 30 min until all solution had 
been used.  
 
3.2.2 AlexaFluor568-MAL  
1.14 µmol (content of one commercially available vial) of AlexaFluor568-MAL and the 
equimolar amount of the previously synthetized conjugate DSPE-PEG2000-MAL-
propanedithiol were each dissolved in 1.5 ml of 100 mM Hepes. Both solutions were 
combined in a brown glass bottle and allowed to react while stirring for 24 h at 4 
0
C. 
 
3.2.3 Peptides 
 2 µmol of the respective peptide and DSPE-PEG2000-MAL were each dissolved in in 
1 ml of 1 mM HEPES. Thereafter, both were combined in a brown glass bottle and in-
cubated for 24 h under stirring at 4 
0
C.  
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3.2.4 Yield calculation 
Yields in percentage of recovered mass were calculated according to the following 
equation and presented in Table 6: 
 
           
               
                       
      
 
3.2.5 Column purification of conjugates 
All conjugates were purified for mass spectrometric analysis by PD-10 desalting 
columns (GE Healthcare) with MilliQ water as eluent at RT. Columns were first 
equilibrated with four times 5 ml MilliQ water. To each column 2.5 ml of sample 
solution was applied and the flow through discarded. In case sample volume was less 
than 2.5 ml, the volume was filled up with MilliQ water. Three elution steps per column 
were performed and eluates collected separately: 0 – 1.5 ml, 1.5 – 3.5 ml and 3.5 – 5.5 
ml. All eluates were further subjected to MALDI-TOF analysis. 
 
3.2.6 Lyophilization of conjugates 
The respective eluates containing significant amounts of conjugate as confirmed by 
MALDI-TOF were combined and lyophilized for further use. Therefore, conjugates in 
MilliQ water were transferred to glass tubes covered by slightly perforated parafilm and 
frozen to prevent sputtering during the lyophilization process. The lyophilization was 
performed in a Lyo Pro 3000 Lyophilizer (Heto/Holten AS) for 48 h for a volume of 5 
ml. 
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3.3 Physicochemical characterization of polymeric micelles 
3.3.1 MALDI-TOF analysis of conjugates 
For MALDI-TOF, polymer and peptide standards were used at 4 mg/ml and eluates 
were not diluted prior analysis. For the measurement, 1 µl of sample and matrix solution 
(saturated α-Cyano-4-hydroxycinnamic acid) were combined on the target and allowed 
to air dry. The matrix-assisted laser desorption/ionization time-of-flight experiments 
were performed using a MALDI/TOF-TOF Ultraflex instrument (Bruker Daltonics, 
Bremen, Germany). The parameter settings were optimized for analyses of peptides up 
to 5000 mass-to-charge ratio (m/z). For external calibration Peptide calibration standard 
I (Bruker part # 206195) was applied. The N2 laser (λ = 337 nm) was used at 50 Hertz. 
Result where analyzed with FlexControl software designed to configure and operate 
time of flight mass spectrometer of the Bruker flex-series. 
 
3.3.2 Size determination 
DLS measurements were performed to determine the size of micelles under different 
conditions. All measurements were carried out using a sample volume of 100 µl/well in 
96-well plates on the Zetasizer APS (Malvern Instruments). Thus, the setup and analysis 
were carried out by Malverns Zetasizer Software V.7.02. The size of the micelles was 
determined using the ‘number’ criteria as described in more detail in chapter 2.5.2. 
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3.3.3 Transmission Electron Microscopy imaging 
Micelle samples were imaged with a FEI Tecnai 12 Transmission Electron Microscope. 
Therefore 2 µl of sample were added to a TEM carbon grids 300 mesh (Pelra) and 
allowed to dry for 30 sec. 10 µl of 2 % uranyl acetate were added and the grid was 
further incubated for 1 min. Finally residual liquid was removed with paper and the grid 
was transferred into the electron microscope for measurement.  
 
3.3.4 Critical Micelle Concentration 
The CMC was determined by the pyrene method described in chapter 2.2.2. First, a 
dilution series of the micellar solution in both, 10 mM and 1 mM HEPES buffer, was 
prepared. The polymer concentration ranged from 0.00356 µM to 721 µM DSPE-
PEG2000. 1 µl of 1 mM pyrene (Fluka) in DMSO was added to 200 µl/well of micellar 
dilution in a 96 well plate and samples were mixed thoroughly. The control samples for 
each series consisted of 200 µl pure buffer with and without 1 µl pyrene. After 
excitation at λEX = 339 nm, fluorescence was measured at λEM = 373 nm and 383 nm 
respectively by Varioscan Flash spectral scanning multimode reader.  
 
3.3.5 Calculation of Critical Micelle Concentration 
The ratio of the emissions at 373/383 nm was plotted against the log C, which repre-
sents the polymer concentration in a logarithmic scale  (Figure 16). A horizontal and a 
sloped trendline could be added to the measurement points. The anti-logarithmic x-
value from the point of intersection of both trendlines represents the CMC of the formu-
lation. 
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Figure 16. Example graph derived from non-labeled micelles in 1 mM HEPES, used for 
the calculation of CMC. The ratios of the emissions at λ = 373 and λ = 383 were plotted 
against the logC of the polymer. A horizontal (red) and a sloped (blue) trendline could 
be added to the measurement points. The x-value of the intersection point of both 
trendlines represents the CMC. 
 
3.4 High Content Screening  
Quantitative HCS analysis was carried out using the cytometer Cellomics Cell Insight 
(Thermo Scientific). Intracellular localization was investigated by Leica TCS SP5II 
HCS A confocal microscope (Leica). For the microscopic experiments cells were cul-
tured in 96-well plates  and  stained as described in the sections 3.5 and 3.6.  
 
3.4.1 Image acquisition by Cellomics Cell Insight 
Pictures were recorded using an Olympus UPlanFL N 10x/0.3 (air) objective. The re-
spective excitation LEDs and emission filters were chosen according to Table 1 and 
the emission spectra visualized in Figure 17. Each well was divided into 49 acquisition 
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fields. For image acquisition autofocus was set to detect nuclei with an acquisition time 
of 0.4 sec. Images were analyzed and processed by iView software (Thermo Scientific). 
Table 1.  Excitation LEDs and emission filters available for the Cellomics Cell Insight. 
The filters for the respective fluorescent dyes were chosen according to their emission 
spectra. 
Excitation 
LEDs:  λEX (nm) 
Quad dichroic emit-
ter filter set: λEM 
(nm) 
λEM 
(nm) 
Dye 
Cellular 
stain 
386±23  440±40  
   485±20  521±21  523 SytoxGreen Nucleus 
549±15  607±34  603 AlexaFluor568 Micelles 
630±13  700±45  702 AlexaFluor680Phalloidin Actin 
 
 
Figure 17. Emission spectra of the applied fluorescent dyes with the respective emis-
sion filters used in the Cellomics CellInsight (highlighted areas). (Life Technologies 
2012) 
 
3.4.2 Quantitative data analysis 
The images were analyzed by Spot Detector V4 (Thermo Scientific Cellomics) soft-
ware. The object detection was set as a ring around the nuclei (Figure 18). Moreover, 
the detection area for micelle spots was extended by a 5 pixel wide circle around the 
521/21 Em-filter
SytoxGreen
607/34 Em-filter
AlexaFluor568
700/45 Em-filter
AlexaFluor680Phalloidin
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nuclei. Settings for micelle spot detection were adjusted by vision to the most reliable 
shapes and fluorescence intensities. For the first experiment only three out of plenty 
possible parameters were subjected to analysis (Table 2). 
Table 2. Description of features selected for analysis in each well by Spot Detector V4 
software. 
Well feature Feature description 
Mean Object Spot total 
Count  
Average number of spots per object (=cell). 
High% Object Spot total 
Count 
Percentage of selected objects with spots features above 
the high response settings. 
Low% Object Spot total 
Count 
Percentage of selected objects with spots features below 
the low response settings. 
 
Figure 18. Spot analysis as performed by the Cellomics Spot Detector V4 software. A: 
nuclei (blue circle) are detected by set criteria. The detection area for micelle spots (or-
ange, highlighted by red arrow) was increased by a 5 pixel wide circle (green line) 
around the nucleus. B: example of micelle spot analysis in a single acquisition field as 
described in A. Cells were further visualized by actin staining (grey) and some micelle 
spots are highlighted by red arrows. 
 
A B
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3.4.3 Confocal fluorescence scanning microscopy 
The Leica TCS SP5II HCS A Confocal microscope was operated with Matrix software 
(Leica) and pictures were acquired through an HC PL APO 20x/0.7 CS (air) objective.  
 
3.5 Cell culture methods 
3.5.1 ARPE-19 cell culture 
The human retinal pigmented epithelium derived cell line ARPE-19 (ATCC
®
 CRL-
2302
™
) was cultured for cytotoxicity assays and micelle-uptake studies. Cells were cul-
tivated under an atmosphere of 7 % CO2 at 37 
°
C in Dulbecco’s Modified Eagle’s Me-
dium (DMEM) (Gibco) F1231330 supplied with 10 % heat inactivated FBS (Gibco), 1 
% penicillin/streptomycin-antibiotics (p/s-antibiotics) (Gibco) and 1 % Glutamax 
(Gibco). Only cells with passage numbers between 27 and 35 were used in the experi-
ments. 
 
3.5.2 Passaging of ARPE-19 
Cells were grown in 200 ml culture flasks (Corning) and passaged once a week at a ra-
tio of 1:5 with an additional change of medium after three days. 
 For passaging, old medium was aspired and cells were washed with sterile 1 x Phos-
phate Buffered Saline (PBS) (-Ca2/-Mg2). Cells were detached by 2.5 ml TrypleExpress 
(Gibco) and incubated for 1 min at room temperature (RT). Thereafter, the liquid was 
aspirated and the flask was incubated for another 10 min in the incubator. Cells were 
finally resuspended by rinsing the flask with 5 ml cell culture medium by intense up and 
down pipeting. 1 ml of cell suspension was transferred into a new 200 ml flask prefilled 
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with 11 ml pre-warmed cell culture medium. For the medium change after three days, 
old medium was aspired and replaced with 12 ml fresh cell culture medium. 
 
3.5.3 Cultivating ARPE-19 cells in 96-well plates 
Cells grown to confluency were detached as described in the former section. Though, 
cells were resuspended in 10 ml of cell culture medium. For cell density determination 
10 µl of a 1:1 mixture of cell suspension and TryptanBlue (Life Technologies) were 
pipetted into a counting chamber and the measurement was performed by Cedex XS 
automated cell counter (Innovatis). 20 000 cells/well, each in a volume of 150 µl, were 
seeded into a black 96 well, tissue culture treated polystyrene plate with clear bottom 
and lid (Corning) and grown to confluency for 24 h at 37 
0
C/7 % CO2. Though, some 
cytotoxicity experiments were perfomed in 96-well, crystal-clear polystyrene plates 
with lid (Greiner). 
 
3.6 Cell staining 
For microscopic analysis ARPE-19 cells in 96-well plates (Corning) were fixed and 
stained with SytoxGreen (Life Technologies) for the nucleus and 
AlexaFluor680Phalloidin (Life Technologies) for actin. The whole staining procedure 
was performed in the dark. 
 
3.6.1 Fixation of ARPE-19 cells 
Medium was aspirated and cells were washed twice with 200 µl of 1 x PBS. Then, 100 
µl of pre-warmed (37 
°
C) 4 % paraformaldehyde (PFA) in 1 x PBS was added to each 
well and incubated at RT for 10 min. Cells were washed two to three times with 200 µl 
42 
 
of 1 x PBS. The last washing step was incubated for 10 min. Permeabilization of cells 
was performed with 100 µl of 0.1 % Triton X-100 in 1 x PBS and incubated 5 min at 
RT. Finally, cells were washed three times for 2 min with 200 µl 1 x PBS. 
 
3.6.2 AlexaFluor680Phalloidin: actin staining 
100 µl/well staining solution (10 µl methanolic stock solution + 90 µl 1 x PBS) was 
added and incubated for 20 min at RT followed by two washes in 200 µl 1 x Hank’s 
Buffered Salt Solution (HBSS) (Gibco). 
 
3.6.3  SytoxGreen: nuclear staining 
SytoxGreen staining was performed with 100 µl of a 5 nM staining solution in 1 x 
HBBS and incubated for 30 min at RT. Thereafter, the cells were washed twice for 10 
min with 200 µl of 1 x HBSS. Finally, cells were covered with 200 µl of 1 x HBSS and 
immediately transferred to microscopic analysis. Stained cells were stored at 4 
°
C up to 
one week. 
 
3.7 Alamar Blue cytotoxicity assay and HCS cell culture experiment 
All steps were performed protected from light. Full cell culture medium was replaced 
with 150 µl of serum free medium per well. The calculated amounts of micelle stock 
solution, according to Table 3, were added in triplicates and mixed by pipetting. For 
negative controls 10 µl of the respective buffers were applied to at least 12 wells on the 
same plate. As a positive control, 10 µl/well of the cytotoxic polymer Polyethylene 
imine (PEI) (branched, 25 kDa, 0.9 mg/ml in MilliQ water, pH 7.2, Sigma Aldrich) was 
added in triplicates to each plate. Micelles were incubated at 37 
0
C/ 7 % CO2 for 24 h. 
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Thereafter, the micelle solution was replaced with 135 µl full cell culture medium and 
15 µl Alamar Blue solution was added to each well. A reduction of the Alamar Blue 
reagent resazurin to the highly fluorescent resorufin in non-damaged cell samples was 
allowed for 2 h at 37 
0
C/ 7 % CO2. Finally, fluorescence (λEX = 540 nm; λEM = 590 nm) 
was measured by Varioskan Flash spectral scanning multimode reader (Thermo Scien-
tific).  
The concentrations of micellar solutions for the HCS experiment were chosen according 
to the results of the cytotoxicity assay and set to 400 µM, which were pipetted in dupli-
cates into black 96 well plates according to Table 3. Only all 10 % peptide labeled mi-
celles were applied at concentrations of 60 µM due to their higher toxicity. 
Table 3. Final concentrations (µM) of micelles as applied in cytotoxicity testing and 
microscopic analysis. The indicated volume of stock solutions was added to serum free 
medium to result in a final volume of 150 µl. 
Final C/well (µM) 10 20 40 60 80 100 200 400 600 800 1000 
V/well (µl) of 
added micelle 
stock 
4.2 8.4 1.7 2.5 3.3 4.2 8.4 16.9 2.5 3.3 4.2 
C (µM) micelle 
stock 
356 3560 35600 
 
 
 
4 RESULTS 
4.1 Characterization of non-labeled DSPE-PEG2000 micelles. 
4.1.1 Effect of ionic strength on micelle size 
The self-assembly of 356 µM (1 mg/ml) DSPE-PEG2000 was tested in MilliQ-water 
and HEPES buffer of four different ionic strengths: 1 mM, 10 mM, 100 mM and 1 M at 
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a polymer concentration of 356 µM. The samples were analyzed by DLS for their diam-
eter and polydispersity. Samples assembled in 1 mM, 10 mM and 100 mM HEPES 
showed reasonable micelle sizes, varying from about 3 to 13 nm in diameter (Table 4). 
The smallest micelles with 3 to 4 nm, were found in 1 mM HEPES. Diameters < 1 nm, 
as observed in MilliQ-water and 1 M HEPES, are likely to represent free monomers.  
Polydispersity should be as low as possible. The lowest polydispersities (< 0.1) were 
found in 1 mM (pdl = 0.078) and 10 mM (pdl = 0.049) HEPES. Thus, 1 mM and 10 
mM HEPES seemed to be the most suitable media for the self-assembly of DSPE-
PEG2000 micelles and were applied in further experiments. 
Table 4. Self-assembly of DSPE-PEG2000 micelles in MilliQ water and HEPES buffer 
of different ionic strengths. Micelle diameters and polydispersity (pdl) were monitored 
at the same time. 
  MilliQ-water 1 mM Hepes 10 mM Hepes 100 mM Hepes 1 M Hepes 
diameter(nm) 0.99 3.63 11.22 12.64 0.74 
pdl 0.2 0.078 0.049 0.145 0.918 
 
 
4.1.2 Effect of polymer concentration on micelle size  
DSPE-PEG2000 was assembled in 1 mM and 10 mM HEPES over a wider concentra-
tion range from 0.1 µM to 5 mM each. As shown in Figure 19, the size of micelles in 10 
mM HEPES is quite constant, with 12 to 13 nm, over a wide concentration range be-
tween about 0.5 µM and 1 mM DSPE-PEG2000. At higher and lower polymer concen-
trations, the size drops quickly. However, in 1 mM HEPES, micelle size is much more 
sensitive to changes in polymer concentration. Although, micelles in 1 mM HEPES 
reach the same maximum size as those in 10 mM HEPES at 10 µM DSPE-PEG2000, 
the micelle size decreases steadily with rising polymer concentration. 
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Figure 19. Size distribution of DSPE-PEG2000 micelles in 1 mM and 10 mM HEPES 
over a wide concentration range. 
 
4.1.3 Stability of micelles over time 
The stability of micelles at a DSPE-PEG2000 concentration of 356 µM was assessed by 
DLS size measurements over several days up to 7 weeks. Table shows that micelles in 1 
mM and 10 mM HEPES keep stable over a time period of at least 7 weeks at this con-
centration.  
Table 5. Diameter (nm) of micelles in 1 mM and 10 mM HEPES from the time point of 
self-assembly (0 h) up to 7 weeks (1008 h). 
 
time (h) 
 0 24 48 1008 
1 mM Hepes 3.63 3.88 3.46 3.63 
10 mM Hepes 11.22 11.24 10.68 11.22 
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4.1.4 Critical micelle concentration 
The CMC of micelles assembled in 1 mM, 10 mM and 100 mM HEPES was deter-
mined by the pyrene method. The results showed CMC values in the range of 0.1-1 µM 
for the micelles in 10 mM HEPES and 1 - 4 µM for the micelles in 10 mM HEPES 
(Table 7). CMC of the micelles in 100 mM HEPES was in the same range as in 10 mM 
HEPES (data not shown).  
 
4.1.5 Cytotoxicity of micelles 
The cytotoxicity was determined by Alamar Blue assay during three days after micelle 
incubation and compared to the corresponding micelle size. Figure 20 A indicates that 
polymer concentrations of > 400 µM in 1 mM HEPES were toxic to ARPE19 cells. 
Though, in 10 mM HEPES cytotoxicity was evitable only at DSPE-PEG2000 concen-
trations > 600 µM (Figure 20 B). The cytotoxicity did not change significantly during 
three days. However, a correlation of cytotoxicity and micelle size could not be shown. 
In 1 mM HEPES micelles of 400 µM and 600 µM polymer were of almost same size, 
2.8 nm and 3.5 nm respectively. Though, in 1 mM HEPES, the 2.8 nm micelles at 600 
µM polymer were clearly cytotoxic, whereas the 3.5 nm micelles at 400 µM polymer 
were not(Figure 20 A). Moreover, micelles in 10 mM HEPES, at the respective  poly-
mer concentrations and diameters of 9.8 and 10.4 nm, showed cytotoxicity, though to a 
lesser extent (Figure 20 B).    
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Figure 20. Cytotoxicity in ARPE19 cells was measured over three days in a concentra-
tion range between 10 µM and 1 mM DSPE-PEG2000  in A:  1 mM HEPES and B:  10 
mM HEPES. 
 
4.2 Assembly and characterization of labeled micelles 
4.2.1 Conjugate yields 
The yields of the conjugation reactions varied from 52 to 90 % and are presented in Ta-
ble 6. 
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Table 6. Amounts and masses of reactants used in the conjugation reactions and the 
respective yields. 
Reactants 
Amount of 
reactants 
(µmol) 
Theoretical 
mass (mg) 
Recovered 
mass  (mg) 
Yield (%) 
DSPE-PEG + dithiol 2 6.06 4.6 75.86 
DSPE-PEG-dithiol + Alexa568 1.14 4.43 4 90.28 
DSPE-PEG + RGD 2 7.71 5 64.84 
DSPE-PEG + TAT 2 9.46 4.93 52.11 
 
 
4.2.2 Conjugate verification: MALDI-TOF 
The successful conjugation of DSPE-PEG2000-MAL-RGD (M = 3855.62 g/mol) and 
DSPE-PEG2000-MAL-TAT (M = 4729.87 g/mol) was assessed by MALDI-TOF 
(Figure 21). Both conjugates showed peaks at the molecular weight of the respective 
conjugate (green arrows), which were absent in the corresponding peptides (red arrows 
and spectra) and non-conjugated DSPE-PEG2000-MAL. The non-conjugated polymer 
was further identified by a relatively high, characteristic peak at M = 906 g/mol (black 
arrow).  
The conjugation of DSPE-PEG2000-AlexaFluor568 could not be verified by MALDI-
TOF, since the fluorescence dye was not suitable for this analysis method. Though, the 
successful conjugation was assumed by a clear blue front during column purification of 
the conjugate. Moreover, the fibrous consistence of this lyophilized conjugate pointed to 
a successful conjugation reaction (data not shown). This front was clearly distinct from 
the front of residual non-conjugated dye. The chemical structure of all conjugates is 
illustrated in the Appendix. 
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Figure 21. Characteristic MALDI-TOF spectra of A:  DSPE-PEG2000-MAL, B:  
DSPE-PEG2000-MAL-RGD conjugate and D:  DSPE-PEG2000-MAL-TAT conjugate. 
C: Enlarged peak distribution of the non-fragmented DSPE-PEG2000-MAL-RGD con-
jugate, which is missing in the spectra of the RGD peptide (red). Correspondingly, E 
compares the characteristic peak distribution of the DSPE-PEG2000-TAT conjugate 
versus TAT peptide (red). Black arrows indicate characteristic peaks for DSPE-
PEG2000, red arrows indicate characteristic peaks for the respective peptide and green 
arrows indicate characteristic peaks for the respective conjugate. 
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4.2.3 Stability of labeled micelles over time 
Interestingly, all higher concentrated (3.56 mM) stock solutions in 1 mM HEPES, 
whether labeled or non-labeled, formed a white precipitate after two weeks in solution 
(Figure 21). Though, the supernatant was stained pink according to the fluorescence 
dye. The white precipitate was non-soluble and even vortexing resulted only in a turbid 
suspension. The same phenomenon did never occur in 10 mM HEPES or at polymer 
concentrations ≤ 356 µM in both buffers.  
 
Figure 22. Five week old samples of DSPE-PEG2000-RGD (5 %) in 10 mM HEPES 
(left) and 1 mM HEPES (right).  A white precipitate has formed in the 1 mM HEPES 
sample after two weeks. 
 
4.2.4 Size of labeled micelles 
The diameter of all labeled micelles at polymer concentrations of 0.045 µM to 356 µM 
was derived by DLS and compared to the non-labeled micelles in the respective buffer. 
The dilution series were prepared from a 3.56 mM micelle stock solution. All labeled 
micelles in 10 mM HEPES exhibited the same size distribution as their non-labeled 
counterpart, still after five weeks (Figure 23 A and B). Even micelles size in 1 mM 
HEPES (measured only for 10 % peptide labeling) was identical with the respective 
non-labeled micelles, when measured within two weeks after assembly (Figure 23 C). 
Though, after two weeks only higher molecular structures (few hundreds to few thou-
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sand nm in diameter) could be detected, which points to a kind of aggregation (Figure 
24).  
 
Figure 23. Size of labeled micelles in solution was determined by DLS and compared 
to the respective non-labeled micelles. A: RGD-labeled micelles in 10 mM HEPES, B: 
TAT-labeled micelles in 10 mM HEPES and C: 10 % RGD- and TAT-labeled micelles 
in 1 mM HEPES. 
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Figure 24. DLS size measurements of labeled micelles from precipitated stocks. A: 
RGD-labeled micelles in 1 mM HEPES and B: TAT-labeled micelles in 1 mM HEPES. 
 
4.2.5 Critical micelle concentration 
The CMC of labeled micelles was determined by the pyrene method and compared to 
stability data derived by the former DLS measurements (Figure 23, Figure 24), whereas 
the starting point of drop in micelle diameter ≤ 1 nm was assumed to equal the CMC. 
DLS measurements were performed on all peptide labeled micelles, whereas the pyrene 
method was applied only to 10 % peptide labeled micelles.  
The results in Table 7 show, that in 1 mM HEPES, labeling did not significantly affect 
the CMC. However, in 10 mM HEPES, labeling led to higher CMC values and thus 
destabilization of micelles. In general, the CMC values of both analytical methods were 
in line with each other (Table 7). Only 10 % TAT-labeled micelles in 10 mM HEPES 
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showed an over four times reduced CMC when measured by pyrene fluorescence. Other 
than in non-labeled micelles, the differences in CMC values of labeled micelles in 1 
mM and 10 mM HEPES were marginal, with the exception of 10 % RGD-labeled mi-
celles in 10 mM HEPES. 
Table 7. CMC (µM) of labeled and non-labeled micelles, measured by the pyrene 
method compared to estimated CMC values derived by DLS.  1 % and 5 % peptide la-
beled micelles have not been determined by the pyrene method, nor precipitated mi-
celles in 1 mM HEPES. 
  
 
CMC (µM) 
      TAT RGD 
  Method non-labeled 1 % 5 % 10 % 1 % 5 % 10 % 
1 mM Hepes 
Pyrene 1 - 4 
  
4.1   
 
3.8 
DLS        1  
  
4.5 
  
4.5 
10 mM Hepes 
Pyrene 0.1 - 1     4.2     11.67 
DLS 0.1 35.6 17.8 17.8 35.6 17.8 17.8 
 
 
4.2.6 Cytotoxicity of labeled micelles 
The cytotoxicity of labeled micelles in solution was assessed with the Alamar Blue test 
after 24 h. Only polymer concentrations from 400 µM to 10 µM, which were proven 
non-toxic in all non-labeled micelles, were tested. No significant cytotoxicity was de-
tected in all samples with 1 % and 5 % peptide labeling, at 1 mM and 10 mM HEPES 
(Figure 25). In contrast, cell viability > 100 % (even up to 160 %) was detected in sev-
eral samples. However, the samples containing 10 % peptide labeling showed cytotoxi-
city at polymer concentrations > 60 µM, except for 10 % TAT-labeled micelles in 10 
mM HEPES (Figure 25 D). In this sample no cytotoxic effects were found at all tested 
concentrations. 
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Figure 25. Cytotoxicity of labeled micelles at various concentrations after a 24 h incu-
bation. Each graph contains micelles with three peptide ratios (1 %, 5 % and 10 %). A:  
RGD labeled micelles in 1 mM HEPES, B: RGD labeled micelles in 10 mM HEPES, C: 
TAT labeled micelles in 1 mM HEPES and D: TAT labeled micelles in 10 mM HEPES. 
 
4.2.7 Micelle shape 
The shape of the labeled micelles was assessed by TEM. Non-labeled and RGD-labeled 
micelles at a concentration of 3.56 mM in 1 mM and 10 mM HEPES were assessed. 
Though, all micelles at 1 mM HEPES were precipitated at that time point.  Irrespective 
of labeling, no micelles could be detected in 1 mM HEPES samples, but dark, seaweed-
like shapes appeared (Figure 26 A and C). At higher magnification the lamellar struc-
ture of those shapes emerged in RGD-labeled samples (Figure 26 C). On the other hand, 
RGD-labeled micelles in 10 mM HEPES showed a real translucent multilayer structure. 
However, these multilayers did not form vesicles as it is known from liposomes, but 
appeared as more or less curved fragments (Figure 26 D).  Finally, lamellar structures 
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were absent in non-labeled micelle samples in 10 mM HEPES, instead star-shaped ag-
gregates were detected (Figure 26 D).  
 
Figure 26. TEM images of micelles at 3.56 mM. A:  DSPE-PEG2000 in 1 mM HEPES,  
B:  DSPE-PEG2000 in 10 mM HEPES,  C:  DSPE-PEG2000-RGD in 1 mM HEPES at 
two magnifications and D:  DSPE-PEG2000-RGD in 10 mM HEPES. Arrows indicate 
lamellar structures. 
 
4.3 HCS analysis 
4.3.1 Image acquisition: Cell Insight Cytometer 
Uptake and localization of all labeled micelles in duplicates were visualized after 24 h 
incubation. The automated image acquisition resulted in pictures of different fluores-
cence intensities between the wells (Figure 27). Even the 49 acquisition fields within 
one well exhibited inhomogeneous fluorescence intensities. Figure 28 shows the non-
1 µm
A B
C D
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homogeneity of two recorded acquisition fields in respect to cell count and cell layer 
confluency.  
 
 
 
Figure 27. A screen snapshot of the analysis window of all wells (small window) and 
one single well, devided into 49 aquisition fields (big window). Green: nucleus, red: 
Alexa568 and grey: actin. 
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Figure 28. Composite pictures of cell stainings in 1 mM HEPES, as seen with the Cell 
Insight. Orange spots indicate Alexa568 fluorescence, some of which are highlighted by 
white arrows. Green: nucleus and grey: actin staining. A: Control micelles, labeled with 
only Alexa568-labeled. B: 10 % TAT-labeled micelles. 
 
4.3.2 Image analysis settings of spot detection software 
The images were analyzed by automated spot detection software, whereas the detection 
of micelles (spots) was limited to the nuclei as target region, enlarged by a 5 pixel wide 
ring as described in chapter 3.4.2. Figure 29 visualizes the automated detection of nu-
clei, whereas by these settings partly several nuclei were joined to one analysis object. 
Thus, the right setting for detection of nuclei, as well as for micelles should still be op-
timized. 
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Figure 29. Automatic nuclear detection by Spot Detector V4 software (blue line). Ac-
cording to the given settings some nuclei were merged and thus treated as one object in 
the analysis for micelle spots (red). 
4.3.3 Micelle localization and quantification : Cell Insight 
In order to compare the drug delivery characteristics of the micellar library, spot count 
analysis was performed with the features listed in Table 2. The ”Mean object total spot 
count” reflects the mean number of spots per cell. Whereas the “% High object spot 
total count” describes the percentage of cells, which contain spots with values over the 
chosen limits. Correspondingly, the “% Low object spot total count” represents the per-
centage of cells below the chosen settings.  
As shown in Figure 30, the mean number of micelles per cell is much higher in control 
micelles labeled solely with Alexa568 than in most peptide labeled micelles in the same 
buffer. In 1 mM HEPES, rising TAT content led to increased micelle count per cell. In 
contrast, RGD-labeled micelles in 1 mM HEPES did not show this tendency. In 10 mM 
HEPES both, TAT and RGD-labeled micelles showed a decrease in spot count with 
increasing peptide concentration. However, this decrease was most striking between 1 
% and 5 % TAT-labeled micelles and marginal in RGD-labeled micelles. Moreover, 
some spots were detected even in non-labeled micelle control samples in 10 mM 
HEPES. The % High object spot total count followed exactly the same pattern than the 
mean micelle count (Figure 30). The % Low object spot total count was 0 for all sam-
ples (data not shown). Moreover, the spot count values of the replicates differed strik-
ingly for certain micelle samples (data not shown).  
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Figure 30. A shows the mean number of micelles (spots) per cell (object), which ful-
filled the given limits. Respectively, B illustrates the percentage of detected micelles, 
which lay over the set limits.  
 
4.3.4 Micelle localization: confocal fluorescence microscopy 
The intracellular localization of 1 % TAT-labeled micelles was confirmed by Leica 
HCS confocal microscope.  
Figure 31 indicates an association of the micelles with the cells. In Figure 31 B, the red 
micelle staining is fainter over the nucleus, which points to an intranuclear localization. 
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The yz-section of a micelle containing cell in Figure 31 C confirmed the association of a 
micelle (red) which the nucleus (green).  
 
 
 
 
Figure 31. 1 % TAT-labeled micelle localization was visualized by Leica HCS confocal 
microscopy with the nucleus stained green, actin violet and micelles red. Micelle spots 
are emphasized by white arrows. A: Overview over a cell areal. B: Enlarged view of a 
celle containing micelles in the nucleus. C: A yz-section of B shows the intracellular 
localization of a micelle.
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5 DISCUSSION 
5.1 Physicochemical characterization of micelles 
Prior to HT/HC analysis, the assembly conditions of the micellar combinatorial library 
had to be tested. Therefore, physicochemical characterization of size, shape and stabil-
ity, as well as the successful conjugation of peptide and fluorescence dye were essential.  
 
5.1.1 Micelle size 
The size of DSPE-PEG2000 micelles was strongly affected by the ionic strength of the 
medium, as well as the polymer concentration. Micelle size in 1 mM and 10 mM 
HEPES, both varied from 1 nm to 12 nm, when assessed over a concentration range 
from 0.1 µM to 5 mM. These findings were in line with published size values of DSPE-
PEG2000 micelles. Vukovic et al. investigated DSPE-PEG2000 micelles in water and 
10 mM HEPES (Vukovic et al. 2011). Their size measurements were carried out at 
much higher polymer concentrations, between 5 and 40 mM. At these concentrations in 
water, they found micelles from 2 to 5 nm and in 10 mM HEPES from 8 to 15 nm. We 
found micelles in a similar size range in both solvent systems, though at much lower 
concentrations.  
The differences in micellar size between the solvent systems could be explained by the 
differences in ionic strength of the solvents (Vukovic et al. 2011). DSPE-PEG2000 pos-
sesses an ionic corona, which is capable of attracting and entrapping counter ions. The 
counter ions shield the charged parts of the corona from Coulombic repulsion among 
each other. Thereby, the effective size of polymer heads decreases, which in turn reduc-
es repulsion between the heads. Thus, more compact packing within a micelle is ena-
bled, which leads to larger micelles with more polymer units/micelle. The higher the 
ionic strength in the medium, the better the shielding capacity. Thus, buffer systems of 
higher ionic strength enable assembly of larger micelles with a higher Nag. Based on 
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computational modeling, Vukovic et al. claimed a Nag of 9 for DSPE-PEG2000 micelles 
in water and a Nag of about 90 in 10 mM HEPES. In addition, a higher ionic strength of 
the solvent weakens interactions between separate micelles in solution. This leads to 
thermodynamically more stable micelles, as can be confirmed by CMC measurement. In 
contrast, in buffers of low ionic strength, the shielding capacity is lower and micelle 
size and stability are more sensitive to other factors, such as polymer concentration. 
Thus, changes in micellar size due to small changes in polymer concentration occur 
more easily, as we observed for micelles in 1 mM HEPES. In contrast, micelles in 10 
mM HEPES showed a constant micelle size over a wide concentration range. 
 The labeling with peptides and fluorescent dye did not affect the micelle size. This re-
sult was surprising, since the peptides added about ⅓ (RGD and Alexa568) and ¾ 
(TAT) to the original molecular size of DSPE-PEG2000. However, the maximum pep-
tide content within micelles is low, with only 1 to 10 % peptides and 1 % Alexa568 
fluorophore. Moreover, there is evidence, that targeting peptides, conjugated to PEG, 
can be co-located within the corona (Lehtinen et al. 2012). Although, hydrophobic pep-
tides were found to be located deeper in the PEG corona than hydrophilic peptides. 
TAT, as well as RGD are mainly hydrophilic and exhibit a net positive charge at physi-
ological pH (Genscript 2013; Miletti 2012). However, it seems possible, that these pep-
tides intrude the PEG corona of the micelles and thereby do not increase the final size of 
the micelles.  
 
5.1.2 Micelle shape 
The shape of DSPE-PEG2000 non-labeled and labeled micelles in 1 mM and 10 mM 
HEPES could not be assessed by TEM analysis. Degradation of micelles during sample 
preparation for TEM by interaction of the micelles with the hydrophobic carbon grid 
might have occurred. Moreover, at the time point of TEM analysis the samples in 1 mM 
HEPES were already precipitated. The precipitates showed a weed-like structure and at 
higher magnifications a lamellar structure could be visualized. It is still unclear whether 
these structures represent aggregated polymers or just artifacts and impurities. However, 
63 
 
these structures were absent in the non-precipitated sample of DSPE-PEG2000-RGD. 
Here, lamellar, curved fractions, which resembled liposomal structures, could be ob-
served. Probably, intact DSPE-PEG2000 micelles cannot be visualized by TEM. 
Vukovic et al. claimed a spherical shape for DSPE-PEG2000 micelles in water and an 
oblate shape in 10 mM HEPES. According to the packing factor P, the micellar mor-
phology changes from spherical to oblate with decreasing size of the head group. The 
shielding of head groups not only leads to a reduction in repulsive forces, but also to a 
reduced effective size of the head group in relation to the lipophilic chains. This could 
explain the difference in predicted shape of these micelles, although we could not con-
firm these findings experimentally. 
 
5.1.3 Micelle stability 
DSPE-PEG2000 micelles have shown to be stable over up to seven weeks in 1 mM and 
10 mM HEPES at a concentration of 356 µM. However, at 3.56 mM, micelles in 1 mM 
HEPES aggregated after about two weeks. A possible explanation could be former men-
tioned reduced stability of micelles in low ionc strength environments. In addition, the 
PEG coronas of micelles can approach and interact more easily with each other in the 
absence of counter ions (Vukovic et al. 2011). This could favour the observed aggrega-
tion. The process of aggregation was slow, but irreversible, since it was not possible to 
recover micelles of original size, as shown in the DLS size measurements. However, the 
aggregates show a lamellar structure, which seems to be thermodynamically favorable 
in this case.  
The CMC of non-labeled micelles, which indicate thermodynamic stability, were in line 
with published values. We found a CMC of 1 to 4 µM in 10 mM HEPES (literature val-
ue for water 1 to 10 µM) and 0.1 to 1 µM in 0.1 mM HEPES (literature value 0.1 to 1 
µM) (Torchilin 2007). Again the higher stability in 10 mM HEPES can be explained by 
stabilization due to more effective shielding of head groups by counter ions as explained 
earlier.  
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However, when comparing non-labeled and labeled micelles in the same buffer system, 
peptide labeling clearly leads to destabilization of micelles. Especially at 10 mM 
HEPES, the labeled micelles exhibited higher CMC values compared to their non-
labeled counterparts.  
The integrity of the PEG corona is one important factor contributing to the stabilization 
of micelles by shielding the hydrophobic parts from the aqueous environment. The hy-
drophilic PEG chains interact with each other’s by van der Waals forces and with the 
aqueous environment by mainly hydrogen bonding or dipole-dipole interactions (Owens 
et al. 2012). TAT, as well as RGD are both capable of interacting with the PEG corona. 
The interaction of peptides with PEG could disrupt the corona and expose the hydro-
phobic core to a more destabilizing environment. In addition, the ratio of hydrophobic 
to hydrophilic chains affects the thermodynamic stability of micelles (Owens et al. 
2012). Increasing the size of the hydrophobic moiety leads to further stabilization of the 
micelles. The peptides increase the hydrophilic part of the polymer and could lead to 
destabilization as observed by a decrease in CMC. 
 
5.2 Conjugations  
5.2.1 Conjugation yields 
The yield of the conjugation reactions was between 52 and 75 %. Only one out of four 
reactions yielded 90 %. Except for the latter, the yield of the click chemistry reaction 
was expected to be higher. The ionic strength of the reaction medium might have had an 
impact on the efficiency of the reaction, even though most click chemistry reactions can 
supposedly be carried out even in water and are not very sensitive to changes in the 
strength of buffers (Hein et al. 2008). On the other hand, the long PEG2000 moiety 
could, by an unfavorable conformation, sterically hinder access to the maleimide group. 
This would clearly impact the final yield. 
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5.2.2 Conjugate verification: MALDI-TOF 
In general, MALDI-TOF is the analytical technique of choice for the verification of 
DSPE-PEG conjugates (Chen et al. 2011). First, we tried to analyze the polymer conju-
gates by electrospray ionization – time of flight (ESI-TOF), which was not successful. 
Only by MALDI-TOF and at polymer concentration as high as 4 mg/ml, we were able 
to get a spectrum of DSPE-PEG2000. The most prominent and characteristic peak of 
the polymer at M = 609 g/mol represented most likely the lipid fragment of DSPE-
PEG2000 as illustrated in Figure 32. Most other peaks of the spectrum were at very low 
intensity. Though, the intact, polymer peaks could be detected as a Gaussian distribution 
of peaks around the molecular weight of the conjugate.  This peak distribution could be 
explained by synthesis driven size variations in DSPE-PEG2000. The commercially 
available polymer is a mix of slightly different sized DSPE-PEG2000 molecules. The 
variations in molecular size originate from slightly variable numbers of PEG-chains per 
polymer. The size of a single PEG chain is about M = 44 g/mol, which is in line with 
the distance of the single peaks of the peak distribution.  However, the spectra of pep-
tide-conjugated DSPE-PEG2000 revealed peaks at the size of the respective conjugate. 
These peaks were absent in the peptide spectra, as well as the non-conjugated DSPE-
PEG2000-MAL. Finally, a successful conjugation was assumed with MALDI-TOF, 
being a suitable analysis method for peptide-polymer conjugates.  
However, the polymer conjugate of AlexaFluor568 could not be analyzed by MALDI-
TOF. The reason for that remains unclear. Nonetheless, a successful conjugation was 
assumed based on a clearly identifiable band during column purification, as well as col-
or and consistency of the lyophilized conjugate.  
 
5.3 Biological micelle effects: cytotoxicity 
In vitro cytotoxicity testing of DSPE-PEG2000 labeled and non-labeled micelles has 
been performed in ARPE19 cell culture to determine biocompatible concentrations for  
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Figure 32. A characteristic lipid fragment with M = 609.02 g/mol from the ionization of 
DSPE-PEG2000-MAL as it was detected with MALDI-TOF. The red arrow indicates 
the site of ionization. 
 
the final HCS experiments. Non-labeled micelles showed a clear concentration depend-
ent cytotoxicity pattern, which was more prominent in 1 mM, but also visible 10 mM 
HEPES. In 1 mM HEPES, cells are viable up to 400 µM, whereas in 10 mM HEPES 
until 600 µM. Though, the cytotoxicity does not seem to be directly related to the size 
of the micelles. A recent study investigated the cytotoxicity of four amphiphilic poly-
meric micelles, one of which was DSPE-PEG2000, on a phagocytic and umbilical vein 
cell line (Zhao et al. 2013). They showed, that cytotoxicity of a particular polymeric 
micellar system varied between cell lines. Their DSPE-PEG2000 micelles, at concentra-
tions between 2 and 30 µM, showed the highest toxicity and apoptosis rate of all four 
tested polymeric micelle systems in an umbilical vein cell line and no toxicity in mac-
rophages. Cell line specificity been shown for micelle uptake mechanisms before 
(Zhang et al. 2013). However, the overall toxicity of DSPE-PEG2000 was still low and 
they did not find any influence of micelles on membrane fluidity. Thus, no membrane 
disruption seemed to have been involved in the cytotoxic effect. Mechanisms for the 
induction of cytotoxicity are manifold and not always fully understood. Cytotoxicity of 
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polymers has shown to increase with molecular size, positive charge and local charge 
density, as well as complexity in conformation (Fischer et al. 2003). However, DSPE-
PEG2000 is not a cationic polymer. In this case cytotoxicity could be mediated by disin-
tegration of micelles. Surfactant properties of polymer units could thus exhibit toxic 
effects on the cells. This would explain the higher toxicity of micelles in 1 mM HEPES, 
since those are less stable.  
The cytotoxicity of peptide labeled micelles was only tested at polymer concentrations ≤ 
400 µM, which had been proved non-toxic in non-labeled micelles. Though, the results 
were not very clear. Cytotoxicity in peptide labeled micelles was only assumed at the 
maximal molar peptide content of 10 % and polymer concentrations ≥ 60 µM, although 
not for 10 % TAT micelles in 10 mM HEPES. However, there is no evidence that TAT 
or RGD peptide exhibit relevant levels of cytotoxicity (Subrizi et al. 2012; Chen et al. 
2011). RGD peptide conjugation at 5 % to PEGylated cationic liposomes was shown to 
even reduce cytotoxicity of the carrier in ARPE19 cells (Chen et al. 2011). Both pep-
tides exhibit positive net charges at physiological pH, with TAT: +10 and RGD: +1 
(Genscript 2013). Since cationic polymeric structures have been shown to induce cyto-
toxicity via various mechanisms, the charge of the peptides could be linked to the higher 
cytotocitiy at increased peptide contents (Fischer et al. 2003).  
Occasionally, cell viability of up to 160 % was determined in labeled micelles. This 
could be due to the partially overlapping emission spectra of the Alamar Blue dye of the 
cytotoxicity test and the micelle label AlexaFluor568. Although, when measuring 
Alamar Blue emission spectra after incubation of labeled micelles, but before addition 
of Alamar Blue reagent, no signal could be detected. Nonetheless, for further cytotoxici-
ty testing another test system should be used.   
 
5.4 High Content Screening 
The data derived from the HCS analysis are based on one experiment and represent a 
starting point for further optimization of experimental and analytical conditions. 
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The localization of Alexa568 fluorescence, which should represent micelle spots, was 
assessed and quantified in a high throughput manner by confocal fluorescence laser 
scanning microscopy and image cytometry. The confocal microscopic images are a real-
istic optical representation of the specimen. In contrast, image cytometry uses pixel in-
formation, which is based on scattering and fluorescence intensities according to given 
settings, to computationally remodulate the final image (Harnett et al. 2007). Thus, we 
used confocal microscopy for intracellular localization of micelles. In turn, image 
cytometry with its powerful software and the possibility to analyze multiple parameters, 
was used for quantitative analysis of micelles inside and close to the nucleus. 
Confocal fluorescence images of 1 % TAT labeled micelles show Alexa568 fluores-
cence inside the cell, closely associated to the nucleus. The fluorescent spots could rep-
resent micelles or labeled monomers, which was yet not possible to determine. Howev-
er, we assume that the labeled DSPE-PEG2000 micelles are capable of passing inside 
the cell. Though, not all micelle spots were associated with the nucleus or other cell 
structures. Especially in control samples, with micelles bearing only AlexaFluor568, 
plenty of micelle spots were detected outside cellular structures as well. This points to 
substantial background binding. The underlying mechanism, or whether binding is me-
diated by AlexaFluor568 or the non-labeled polymeric micelles, should be further in-
vestigated. The maleimide functionalized AlexaFluor568 dye has a logD7.4 of -7.3, 
which is highly hydrophilic and thus could obstruct membrane permeation by non-
specific interactions (Jones and Sayer 2012). Although, the more likely mechanism of 
micelle uptake is endocytosis and the concentration of AlexaFluor568 is very low (1 
%). Moreover, fixation of cells prior to the analysis has been shown to alter delivery 
patterns of several macromolecules (Richard et al. 2003). Live cell imaging should be 
performed to verify the results of intracellular localization. 
Nuclear association of peptide labeled DSPE-PEG2000 micelles was investigated and 
quantified by Cellomics Cell Insight image cytometer and Spot detection software. The 
HCS functionality for the combinatorial micellar library was tested exemplarily by ana-
lyzing one parameter, the amount of micelle spots within the nucleus, enlarged by a 
circle of five pixels. The definitions of nuclei and micelles were set using shape, form 
and fluorescence intensity factors. Moreover, the amount of spots, which lay over and 
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below the set limits, was analyzed.  The results showed a generally higher amount of 
fluorescence spots per cell for TAT-labeled, compared to RGD-labeled samples. At 10 
mM HEPES the amount of spots per cell was rising with rising peptide ratio, whereas at 
1 mM HEPES it decreased. Especially in 10 mM HEPES fluorescently labeled samples 
without peptide showed the highest counts per cell. Even non-labeled samples in 1 mM 
HEPES exhibited low detectable spot counts, which was higher than in most labeled 
samples. The rising spot count for increasing peptide ratios in TAT-labeled samples in 
10 mM HEPES could point to a peptide dependent uptake mechanism, either passive or 
active. On the other hand, the reverse uptake pattern of TAT-labeled micelles in 1 mM 
HEPES are contradictory. Especially the high spot counts in the control samples cannot 
be explained yet. The read-out of the first HCS experiment is probably not reliable. Ex-
perimental and analytical conditions have to be improved. First, the non-homogeneity of 
the cell layer between the wells, seen in the image recordings, is one source of inaccura-
cy. A uniform cell monolayer exhibits a more regular distribution of nuclei than a dis-
turbed or double layer. This in turn affects the automated nuclear recognition of the spot 
detection software. Therefore, the cell culture and micelle treatment conditions should 
be further optimized for this experiment. The disturbances in cell layer confluency 
could also result from cytotoxicity due to too long incubation or too high polymer con-
centrations. Even though the cytotoxicity test did not reveal significant toxicity for the 
concentrations used in the HCS experiment, it might have not been sensitive enough for 
this purpose. The 24 h incubation turned out to be too long. Also the fixation and multi-
ple staining processes could lead to cell damage and alter results. In addition, we real-
ized a bleaching of the nuclear staining within a few days, so that the concentration of 
SytoxGreen should be further increased for optimal nuclear recognition. Moreover, the 
limited stability of the micelles in 1 mM HEPES has to be taken into account. In this 
HCS experiment the samples in 1 mM HEPES were already precipitated to form other 
supramolecular structures prior incubation to micelles. Nonetheless, fluorescence spots 
were detected and counted in those samples. For future experiments freshly prepared 
micelle solutions should be applied. When comparing the spots per cell and the percent-
age of spots above the limits, both show the same pattern. This means, that there might 
be still plenty of fluorescence spots, which were not counted by the software, since their 
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parameters lay above the set limits. Thus, tuning and optimization of detection parame-
ters should be performed to get more accurate results. 
  
 
6 CONCLUSIONS 
In this thesis, a small combinatorial library of peptide labeled polymeric micelles was 
assembled, characterized and tested with HT/HC analysis in one preliminary experi-
ment. The library was based on DSPE-PEG2000 as polymeric backbone. The micelles 
were found to change size, shape and stability with polymer concentration and ionic 
strength of buffer. Moreover, labeling with peptides and fluorescence dye did not im-
pact the size of the micelles, but lowered their stability. This physicochemical character-
ization of the library consumed substantial amounts of resources and time, and suitable 
methodologies for this particular system had to be found. Methodological challenges, 
which should be further optimized, were the characterization of polymer conjugates by 
MALDI-TOF, which was only detectable at high polymer concentrations, and the TEM 
analysis for micelle shape. DLS for size, as well as pyrene fluorescence for CMC stabil-
ity determination turned out to be suitable methods. However, due to the dynamic na-
ture of micellar systems, the knowledge of physicochemical properties of the micelles 
under various conditions is of great importance. Experimental conditions of biological 
screens for drug delivery properties have to be chosen according to the characteristics of 
the particular system. The preliminary biological HT/HC analysis of this micellar li-
brary in ARPE19 cells revealed intracellular localization and differences in mean spot 
counts per cell among the samples. However, the results were not clear, but revealed 
experimental topics, where further optimization of experimental conditions is needed. In 
general, the screening of a combinatorial nanoparticulate library can be beneficial in 
identification and optimization of nanocarriers for a given application, as well as pro-
vide deeper understanding of their function. Once the library is prepared and character-
ized well, HT/HC analysis can be carried out quickly and analyzed for the parameters of 
interest, and the same library could be used in other screens as well.  
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ABBREVIATIONS 
 
ADME  Absorption Distribution Metabolism Elimination 
ARPE19  Human Retinal Pigmented Epithelium Cells 
BBB  Blood Brain Barrier 
CAM  Cell Adhesion Molecule 
CLSM  Confocal Laser Scanning Microscopy 
CMC  Critical Micellar Concentration 
CME  Clathrin-Mediated Endocytosis 
CPP  Cell Penetrating Peptide 
CvME  Calveolae-Mediated Endocytosis 
DLS  Dynamic Light Scattering 
DMSO  Dimethyl Sulfoxide 
DMEM  Dulbecco’s Modified Eagle’s Medium 
DNA  Deoxyribonucleic Acid 
DSPE  1,2-distearoyl-sn-glycero-3-phosphoethanolamine 
ECM  Extra Cellular Matrix 
EGF  Epidermal Growth Factor 
EPR  Enhanced Permeability and Retention Effect 
ESI-TOF  Electrospray Ionization – Time of Flight 
FDA  Food and Drug Administration 
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GAG  Glycosaminoglycan 
HCS  High Content Screening 
HBSS  Hank’s Balanced Salt Solution 
HEPES  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid  
HepG2  Human Hepatocellular Liver Carcinoma Cells 
HT(S)  High Throughput (Screening) 
HUVEC  Human Umbilical Vein Endothelial Cells 
LED  Light Emitting Diode 
MAL  Maleimide 
MALDI-TOF Matrix Assisted Laser Desorption Ionization–Time of  Flight 
mPEG-PCL-FITC poly(ethylene glycol)-block-poly(ε-caprolactone) fluorescein 
isothiocyanate  
MS  Mass Spectrometry 
PBS  Phosphate Buffered Saline 
pdl  Polydispersity 
PEG  Polyethyleneglycol 
PEI  Polyethylenimine  
PFA  Paraformaldehyde 
PHDCA  Poly(hexadecylcyanoacrylate)  
PMT  Photomultiplier Tubes 
p/s  penicillin/streptomycin 
PVP  Polyvinylpyrollidone 
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RES  Reticulo Endothelial System 
RGD  Arginine-Glycine-Aspartic acid 
RNA  Ribonucleic Acid 
RT  Room Temperature 
SP  Spectrophotometer Detection System (Leica) 
SSS  Solid State Sensors 
TAT  Transactivator of transcription 
TEM  Transmission Electron Microscopy 
UV  Ultraviolett 
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